| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.673 | 0.01 | 0.785 | Aldehyde oxidase inhibitor | 0.72 0.007 CID_439929 0.785 0.005 CID_9543118 0.764 0.005 CID_123074 | CID_9543118 | |
| 0.68 | 0.026 | 0.816 | Caspase 9 stimulant | 0.816 0.009 CID_439929 0.81 0.01 CID_9543118 0.795 0.012 CID_123074 | CID_439929 | |
| 0.651 | 0.004 | 0.671 | GABA C receptor rho-3 antagonist | 0.586 0.009 CID_439929 0.63 0.005 CID_9543118 0.671 0.004 CID_123074 | CID_123074 | |
| 0.656 | 0.01 | 0.695 | 5 Hydroxytryptamine release stimulant | 0.596 0.015 CID_439929 0.596 0.015 CID_9543118 0.695 0.007 CID_123074 | CID_123074 | |
| 0.608 | 0.01 | 0.608 | 5 Hydroxytryptamine release inhibitor | 0.52 0.027 CID_439929 0.52 0.027 CID_9543118 0.559 0.018 CID_123074 | ||
| 0.571 | 0.005 | 0.642 | Peroxidase inhibitor | 0.642 0.004 CID_439929 0.642 0.004 CID_9543118 0.607 0.004 CID_123074 | CID_9543118 | |
| 0.565 | 0.01 | 0.565 | Calcium channel L-type activator | 0.484 0.034 CID_439929 0.484 0.034 CID_9543118 0.518 0.021 CID_123074 | ||
| 0.558 | 0.014 | 0.558 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.41 0.092 CID_439929 0.45 0.061 CID_9543118 0.501 0.033 CID_123074 | ||
| 0.544 | 0.004 | 0.544 | Alpha-N-acetylglucosaminidase inhibitor | 0.361 0.011 CID_439929 0.361 0.011 CID_9543118 0.495 0.005 CID_123074 | ||
| 0.541 | 0.01 | 0.561 | Superoxide dismutase inhibitor | 0.561 0.009 CID_439929 0.561 0.009 CID_9543118 0.521 0.011 CID_123074 | CID_9543118 | |
| 0.515 | 0.024 | 0.529 | Histamine release inhibitor | 0.515 0.024 CID_439929 0.529 0.02 CID_9543118 0.513 0.025 CID_123074 | CID_9543118 | |
| 0.493 | 0.004 | 0.737 | Tyrosine 3 hydroxylase inhibitor | 0.737 0.002 CID_439929 0.641 0.003 CID_9543118 0.635 0.003 CID_123074 | CID_439929 | |
| 0.478 | 0.005 | 0.478 | 5 Hydroxytryptamine uptake stimulant | 0.463 0.006 CID_439929 0.463 0.006 CID_9543118 0.466 0.005 CID_123074 | ||
| 0.45 | 0.004 | 0.45 | GABA C receptor agonist | 0.307 0.009 CID_439929 0.307 0.009 CID_9543118 0.436 0.004 CID_123074 | ||
| 0.47 | 0.027 | 0.47 | MAP kinase kinase 6 inhibitor | 0.273 0.163 CID_9543118 0.342 0.099 CID_123074 | ||
| 0.444 | 0.012 | 0.449 | Calcium channel activator | 0.449 0.011 CID_439929 0.406 0.022 CID_9543118 0.446 0.012 CID_123074 | CID_439929 | |
| 0.419 | 0.034 | 0.419 | Aryl hydrocarbon receptor agonist | 0.318 0.056 CID_439929 0.365 0.045 CID_9543118 0.338 0.051 CID_123074 | ||
| 0.384 | 0.004 | 0.384 | Ferrochelatase inhibitor | 0.199 0.023 CID_439929 0.199 0.023 CID_9543118 0.292 0.008 CID_123074 | ||
| 0.375 | 0.009 | 0.431 | NOS3 expression enhancer | 0.431 0.007 CID_439929 0.327 0.014 CID_9543118 0.243 0.028 CID_123074 | CID_439929 | |
| 0.407 | 0.048 | 0.484 | Cholesterol antagonist | 0.484 0.035 CID_439929 0.458 0.039 CID_9543118 0.463 0.038 CID_123074 | CID_439929 | |
| 0.407 | 0.053 | 0.407 | Vasodilator, peripheral | 0.396 0.056 CID_439929 0.356 0.071 CID_9543118 0.359 0.07 CID_123074 | ||
| 0.369 | 0.021 | 0.369 | Anesthetic general | 0.286 0.037 CID_439929 0.286 0.037 CID_9543118 0.353 0.023 CID_123074 | ||
| 0.361 | 0.022 | 0.361 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.245 0.063 CID_439929 | ||
| 0.357 | 0.022 | 0.357 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.184 0.09 CID_439929 0.18 0.094 CID_9543118 | ||
| 0.358 | 0.023 | 0.446 | RNA-directed DNA polymerase inhibitor | 0.446 0.014 CID_439929 0.434 0.015 CID_9543118 0.444 0.014 CID_123074 | CID_439929 | |
| 0.345 | 0.013 | 0.436 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.391 0.008 CID_439929 0.436 0.006 CID_9543118 0.422 0.007 CID_123074 | CID_9543118 | |
| 0.335 | 0.004 | 0.492 | Alcohol oxidase inhibitor | 0.272 0.005 CID_439929 0.272 0.005 CID_9543118 0.492 0.004 CID_123074 | CID_123074 | |
| 0.334 | 0.011 | 0.439 | Neurotrophic factor enhancer | 0.439 0.005 CID_439929 0.439 0.005 CID_9543118 0.369 0.008 CID_123074 | CID_9543118 | |
| 0.328 | 0.007 | 0.385 | Succinate dehydrogenase inhibitor | 0.385 0.004 CID_439929 0.334 0.007 CID_9543118 0.33 0.007 CID_123074 | CID_439929 | |
| 0.325 | 0.005 | 0.327 | GABA C receptor rho-2 antagonist | 0.235 0.015 CID_439929 0.27 0.008 CID_9543118 0.327 0.004 CID_123074 | CID_123074 | |
| 0.327 | 0.008 | 0.622 | Cystathionine beta-synthase inhibitor | 0.622 0.003 CID_439929 0.612 0.003 CID_9543118 0.557 0.003 CID_123074 | CID_439929 | |
| 0.321 | 0.004 | 0.41 | Phenylalanine 4-hydroxylase inhibitor | 0.41 0.003 CID_439929 0.41 0.003 CID_9543118 0.342 0.004 CID_123074 | CID_9543118 | |
| 0.317 | 0.005 | 0.405 | Porphobilinogen synthase inhibitor | 0.284 0.006 CID_439929 0.284 0.006 CID_9543118 0.405 0.004 CID_123074 | CID_123074 | |
| 0.316 | 0.004 | 0.316 | 5 Hydroxytryptamine 3E antagonist | 0.233 0.026 CID_439929 0.233 0.026 CID_9543118 0.236 0.023 CID_123074 | ||
| 0.335 | 0.03 | 0.413 | Cyclic AMP phosphodiesterase inhibitor | 0.413 0.015 CID_439929 0.375 0.02 CID_9543118 0.355 0.025 CID_123074 | CID_439929 | |
| 0.313 | 0.01 | 0.338 | UDP-glucose 4-epimerase inhibitor | 0.25 0.013 CID_439929 0.25 0.013 CID_9543118 0.338 0.008 CID_123074 | CID_123074 | |
| 0.328 | 0.035 | 0.328 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.334 | 0.04 | 0.344 | Insulysin inhibitor | 0.344 0.036 CID_439929 0.344 0.036 CID_9543118 0.339 0.038 CID_123074 | CID_9543118 | |
| 0.315 | 0.021 | 0.315 | 5 Hydroxytryptamine 1E antagonist | 0.272 0.052 CID_439929 0.272 0.052 CID_9543118 0.266 0.057 CID_123074 | ||
| 0.325 | 0.034 | 0.325 | Sigma receptor agonist | |||
| 0.315 | 0.024 | 0.315 | Gastrin inhibitor | 0.219 0.121 CID_439929 0.226 0.111 CID_9543118 0.267 0.061 CID_123074 | ||
| 0.349 | 0.059 | 0.492 | Caspase 3 stimulant | 0.492 0.021 CID_439929 0.455 0.028 CID_9543118 0.402 0.044 CID_123074 | CID_439929 | |
| 0.291 | 0.005 | 0.302 | T cell inhibitor | 0.101 0.023 CID_439929 0.227 0.006 CID_9543118 0.302 0.005 CID_123074 | CID_123074 | |
| 0.293 | 0.007 | 0.293 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.19 0.017 CID_439929 0.19 0.017 CID_9543118 0.24 0.011 CID_123074 | ||
| 0.331 | 0.046 | 0.411 | DNA damaging | 0.411 0.026 CID_439929 0.411 0.026 CID_9543118 0.391 0.03 CID_123074 | CID_9543118 | |
| 0.338 | 0.054 | 0.514 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.493 0.02 CID_439929 0.514 0.018 CID_9543118 0.494 0.02 CID_123074 | CID_9543118 | |
| 0.318 | 0.04 | 0.325 | Interleukin agonist | 0.275 0.062 CID_439929 0.317 0.04 CID_9543118 0.325 0.037 CID_123074 | CID_123074 | |
| 0.282 | 0.005 | 0.296 | GABA C receptor antagonist | 0.187 0.016 CID_439929 0.216 0.01 CID_9543118 0.296 0.004 CID_123074 | CID_123074 | |
| 0.29 | 0.014 | 0.29 | 3C-like protease (Human coronavirus) inhibitor | 0.226 0.038 CID_439929 0.171 0.073 CID_9543118 0.209 0.047 CID_123074 | ||
| 0.288 | 0.013 | 0.288 | Aldehyde dehydrogenase inhibitor | 0.225 0.022 CID_439929 0.268 0.015 CID_9543118 0.284 0.013 CID_123074 | ||
| 0.288 | 0.015 | 0.288 | Nitric-oxide synthase stimulant | 0.276 0.019 CID_439929 0.276 0.019 CID_9543118 0.285 0.016 CID_123074 | ||
| 0.322 | 0.05 | 0.322 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.198 0.16 CID_439929 0.249 0.108 CID_9543118 | ||
| 0.278 | 0.007 | 0.347 | Mannose-6-phosphate isomerase inhibitor | 0.308 0.005 CID_439929 0.347 0.004 CID_9543118 0.347 0.004 CID_123074 | CID_123074 | |
| 0.304 | 0.034 | 0.304 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.272 | 0.006 | 0.272 | Triose-phosphate isomerase inhibitor | 0.187 0.012 CID_439929 0.187 0.012 CID_9543118 0.246 0.007 CID_123074 | ||
| 0.266 | 0.005 | 0.266 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.176 0.036 CID_439929 0.203 0.017 CID_9543118 0.184 0.029 CID_123074 | ||
| 0.263 | 0.004 | 0.263 | CYP2A6 inhibitor | 0.122 0.026 CID_439929 0.14 0.019 CID_9543118 0.171 0.012 CID_123074 | ||
| 0.295 | 0.037 | 0.295 | MAP kinase kinase 2 inhibitor | 0.19 0.089 CID_439929 0.202 0.081 CID_9543118 0.212 0.074 CID_123074 | ||
| 0.326 | 0.069 | 0.35 | Vasodilator, coronary | 0.327 0.068 CID_439929 0.345 0.058 CID_9543118 0.35 0.055 CID_123074 | CID_123074 | |
| 0.259 | 0.005 | 0.397 | Creatine kinase inhibitor | 0.339 0.004 CID_439929 0.397 0.003 CID_9543118 0.382 0.003 CID_123074 | CID_9543118 | |
| 0.306 | 0.052 | 0.389 | Transcription factor STAT inhibitor | 0.379 0.024 CID_439929 0.389 0.022 CID_9543118 0.383 0.023 CID_123074 | CID_9543118 | |
| 0.298 | 0.044 | 0.359 | DNA synthesis inhibitor | 0.264 0.058 CID_439929 0.301 0.043 CID_9543118 0.359 0.028 CID_123074 | CID_123074 | |
| 0.287 | 0.035 | 0.287 | CDC-like kinase 4 inhibitor | |||
| 0.312 | 0.06 | 0.499 | Hypoxia-inducible factor 1 alpha inhibitor | 0.499 0.015 CID_439929 0.483 0.016 CID_9543118 0.432 0.023 CID_123074 | CID_439929 | |
| 0.35 | 0.099 | 0.591 | 15-Lipoxygenase inhibitor | 0.591 0.025 CID_439929 0.577 0.027 CID_9543118 0.501 0.04 CID_123074 | CID_439929 | |
| 0.255 | 0.005 | 0.255 | CF transmembrane conductance regulator agonist | 0.224 0.012 CID_439929 0.224 0.012 CID_9543118 0.229 0.01 CID_123074 | ||
| 0.254 | 0.005 | 0.254 | 5 Hydroxytryptamine 3A agonist | 0.167 0.027 CID_439929 0.194 0.017 CID_9543118 0.216 0.011 CID_123074 | ||
| 0.253 | 0.004 | 0.253 | GABA C receptor rho-1 antagonist | 0.164 0.016 CID_439929 0.192 0.009 CID_9543118 0.246 0.004 CID_123074 | ||
| 0.276 | 0.031 | 0.276 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.225 0.043 CID_439929 0.148 0.079 CID_9543118 | ||
| 0.295 | 0.056 | 0.383 | Transcription factor STAT3 inhibitor | 0.376 0.024 CID_439929 0.383 0.023 CID_9543118 0.374 0.025 CID_123074 | CID_9543118 | |
| 0.252 | 0.013 | 0.252 | ATPase inhibitor | 0.216 0.026 CID_439929 0.248 0.014 CID_9543118 0.245 0.015 CID_123074 | ||
| 0.244 | 0.005 | 0.244 | MAP3K9 inhibitor | 0.151 0.058 CID_439929 0.161 0.046 CID_9543118 0.185 0.023 CID_123074 | ||
| 0.244 | 0.006 | 0.244 | Photosensitizer | 0.218 0.01 CID_439929 0.178 0.018 CID_9543118 0.202 0.012 CID_123074 | ||
| 0.331 | 0.096 | 0.331 | Calpain 2 inhibitor | 0.252 0.148 CID_123074 | ||
| 0.288 | 0.053 | 0.374 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.372 0.031 CID_439929 0.374 0.03 CID_9543118 0.298 0.051 CID_123074 | CID_9543118 | |
| 0.243 | 0.01 | 0.243 | Adenylate kinase inhibitor | 0.161 0.023 CID_439929 0.161 0.023 CID_9543118 0.226 0.012 CID_123074 | ||
| 0.237 | 0.006 | 0.283 | HIV-1 integrase (Overall Integration) inhibitor | 0.283 0.004 CID_439929 0.283 0.004 CID_9543118 0.253 0.005 CID_123074 | CID_9543118 | |
| 0.278 | 0.049 | 0.278 | Psychostimulant | 0.165 0.104 CID_439929 0.183 0.091 CID_9543118 0.216 0.072 CID_123074 | ||
| 0.247 | 0.018 | 0.273 | Hexokinase inhibitor | 0.244 0.018 CID_439929 0.252 0.017 CID_9543118 0.273 0.014 CID_123074 | CID_123074 | |
| 0.266 | 0.037 | 0.347 | Non-steroidal antiinflammatory agent | 0.347 0.02 CID_439929 0.325 0.023 CID_9543118 0.297 0.029 CID_123074 | CID_439929 | |
| 0.285 | 0.058 | 0.343 | Dyrk kinase inhibitor | 0.341 0.039 CID_439929 0.343 0.039 CID_9543118 0.27 0.063 CID_123074 | CID_9543118 | |
| 0.249 | 0.025 | 0.358 | Phospholipase C inhibitor | 0.249 0.025 CID_439929 0.335 0.015 CID_9543118 0.358 0.014 CID_123074 | CID_123074 | |
| 0.226 | 0.005 | 0.292 | Prolactin inhibitor | 0.292 0.003 CID_439929 0.255 0.004 CID_9543118 0.259 0.004 CID_123074 | CID_439929 | |
| 0.263 | 0.044 | 0.263 | Neuropeptide Y2 antagonist | 0.197 0.125 CID_439929 0.212 0.1 CID_9543118 0.238 0.068 CID_123074 | ||
| 0.246 | 0.027 | 0.26 | Histone acetyltransferase inhibitor | 0.241 0.029 CID_439929 0.26 0.022 CID_9543118 0.24 0.03 CID_123074 | CID_9543118 | |
| 0.252 | 0.034 | 0.338 | Protein kinase C nu inhibitor | 0.338 0.018 CID_439929 0.228 0.039 CID_9543118 0.198 0.048 CID_123074 | CID_439929 | |
| 0.229 | 0.014 | 0.231 | Carbonic anhydrase XV inhibitor | 0.231 0.014 CID_439929 0.231 0.014 CID_9543118 0.2 0.018 CID_123074 | CID_9543118 | |
| 0.305 | 0.091 | 0.505 | Transcription factor NF kappa B inhibitor | 0.505 0.043 CID_439929 0.478 0.048 CID_9543118 0.44 0.055 CID_123074 | CID_439929 | |
| 0.237 | 0.024 | 0.341 | NADPH oxidase inhibitor | 0.305 0.012 CID_439929 0.341 0.008 CID_9543118 0.3 0.013 CID_123074 | CID_9543118 | |
| 0.35 | 0.139 | 0.697 | Apoptosis agonist | 0.697 0.031 CID_439929 0.681 0.034 CID_9543118 0.645 0.04 CID_123074 | CID_439929 | |
| 0.294 | 0.083 | 0.493 | 12-Lipoxygenase inhibitor | 0.49 0.022 CID_439929 0.493 0.022 CID_9543118 0.424 0.033 CID_123074 | CID_9543118 | |
| 0.266 | 0.057 | 0.442 | Pyruvate kinase inhibitor | 0.419 0.017 CID_439929 0.442 0.015 CID_9543118 0.415 0.018 CID_123074 | CID_9543118 | |
| 0.213 | 0.004 | 0.213 | Glutamate release inhibitor | 0.138 0.013 CID_439929 0.156 0.009 CID_9543118 0.172 0.006 CID_123074 | ||
| 0.216 | 0.009 | 0.22 | NADH dehydrogenase inhibitor | 0.172 0.013 CID_439929 0.172 0.013 CID_9543118 0.22 0.009 CID_123074 | CID_123074 | |
| 0.235 | 0.032 | 0.403 | Amylase inhibitor | 0.403 0.009 CID_439929 0.331 0.015 CID_9543118 0.312 0.017 CID_123074 | CID_439929 | |
| 0.22 | 0.017 | 0.228 | Arachidonic acid antagonist | 0.22 0.017 CID_439929 0.225 0.014 CID_9543118 0.228 0.013 CID_123074 | CID_123074 | |
| 0.243 | 0.041 | 0.243 | I kappa B kinase epsilon inhibitor | 0.182 0.087 CID_439929 0.196 0.075 CID_9543118 0.191 0.079 CID_123074 | ||
| 0.216 | 0.015 | 0.216 | Nav1.6 sodium channel blocker | 0.128 0.084 CID_439929 0.149 0.055 CID_9543118 0.16 0.044 CID_123074 | ||
| 0.244 | 0.045 | 0.244 | Growth hormone agonist | 0.153 0.085 CID_439929 0.153 0.085 CID_9543118 0.174 0.071 CID_123074 | ||
| 0.255 | 0.056 | 0.255 | MAP-kinase-activated kinase 5 inhibitor | 0.173 0.143 CID_9543118 | ||
| 0.208 | 0.01 | 0.217 | Adenylate cyclase stimulant | 0.217 0.008 CID_439929 0.217 0.008 CID_9543118 0.214 0.009 CID_123074 | CID_9543118 | |
| 0.24 | 0.043 | 0.24 | LIM domain kinase 1 inhibitor | 0.139 0.11 CID_439929 0.163 0.085 CID_9543118 0.162 0.087 CID_123074 | ||
| 0.209 | 0.014 | 0.209 | Catalase inhibitor | 0.137 0.029 CID_439929 0.17 0.022 CID_9543118 0.195 0.016 CID_123074 | ||
| 0.241 | 0.051 | 0.328 | DNA methyltransferase I inhibitor | 0.328 0.018 CID_439929 0.322 0.019 CID_9543118 0.312 0.022 CID_123074 | CID_439929 | |
| 0.193 | 0.005 | 0.193 | Acetylcholine release stimulant | 0.141 0.022 CID_439929 0.137 0.026 CID_9543118 0.164 0.01 CID_123074 | ||
| 0.223 | 0.035 | 0.223 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.245 | 0.057 | 0.245 | Clk dual-specificity kinase inhibitor | |||
| 0.215 | 0.029 | 0.215 | Neurotensin receptor agonist | 0.192 0.039 CID_439929 0.199 0.035 CID_9543118 0.211 0.03 CID_123074 | ||
| 0.199 | 0.013 | 0.231 | Histidine decarboxylase inhibitor | 0.229 0.01 CID_439929 0.229 0.01 CID_9543118 0.231 0.01 CID_123074 | CID_123074 | |
| 0.191 | 0.004 | 0.199 | Ca2+-transporting ATPase inhibitor | 0.177 0.008 CID_439929 0.185 0.005 CID_9543118 0.199 0.004 CID_123074 | CID_123074 | |
| 0.22 | 0.034 | 0.22 | Cyclooxygenase inhibitor | 0.202 0.041 CID_439929 0.189 0.046 CID_9543118 0.168 0.058 CID_123074 | ||
| 0.193 | 0.008 | 0.259 | DOPA decarboxylase inhibitor | 0.259 0.003 CID_439929 0.259 0.003 CID_9543118 0.242 0.004 CID_123074 | CID_9543118 | |
| 0.194 | 0.01 | 0.408 | Estrogen receptor beta antagonist | 0.408 0.004 CID_439929 0.37 0.004 CID_9543118 0.38 0.004 CID_123074 | CID_439929 | |
| 0.23 | 0.047 | 0.277 | Insulin sensitizer | 0.277 0.022 CID_439929 0.272 0.024 CID_9543118 0.261 0.029 CID_123074 | CID_439929 | |
| 0.192 | 0.009 | 0.192 | Protein kinase C delta inhibitor | 0.147 0.023 CID_439929 0.125 0.034 CID_9543118 0.127 0.032 CID_123074 | ||
| 0.215 | 0.033 | 0.63 | Tubulin antagonist | 0.63 0.005 CID_439929 0.445 0.01 CID_9543118 0.349 0.015 CID_123074 | CID_439929 | |
| 0.195 | 0.014 | 0.195 | Sphingosine 1-phosphate receptor 5 antagonist | 0.176 0.027 CID_439929 0.176 0.027 CID_9543118 0.174 0.029 CID_123074 | ||
| 0.209 | 0.028 | 0.209 | Cyclooxygenase 2 inhibitor | 0.172 0.041 CID_439929 0.156 0.049 CID_9543118 0.139 0.062 CID_123074 | ||
| 0.238 | 0.057 | 0.238 | Death-associated protein kinase 3 inhibitor | |||
| 0.195 | 0.015 | 0.195 | Activin receptor-like kinase 4 inhibitor | |||
| 0.192 | 0.011 | 0.192 | Sphingomyelinase inhibitor | 0.136 0.031 CID_439929 0.136 0.031 CID_9543118 0.142 0.028 CID_123074 | ||
| 0.19 | 0.01 | 0.19 | Glutamate (mGluR) agonist | |||
| 0.265 | 0.085 | 0.351 | Spasmolytic | 0.351 0.052 CID_439929 0.325 0.061 CID_9543118 0.319 0.063 CID_123074 | CID_439929 | |
| 0.247 | 0.068 | 0.247 | Calpain inhibitor | 0.163 0.159 CID_439929 0.199 0.115 CID_9543118 0.216 0.099 CID_123074 | ||
| 0.185 | 0.007 | 0.185 | Biliverdin reductase inhibitor | 0.096 0.02 CID_439929 0.096 0.02 CID_9543118 0.147 0.01 CID_123074 | ||
| 0.228 | 0.05 | 0.228 | Focal adhesion kinase 2 inhibitor | 0.147 0.135 CID_9543118 0.163 0.111 CID_123074 | ||
| 0.217 | 0.039 | 0.217 | Protein kinase (CK1) gamma inhibitor | |||
| 0.192 | 0.013 | 0.193 | Alcohol dehydrogenase inhibitor | 0.164 0.017 CID_439929 0.193 0.013 CID_9543118 0.178 0.015 CID_123074 | CID_9543118 | |
| 0.201 | 0.022 | 0.201 | Cathepsin H inhibitor | 0.13 0.064 CID_439929 0.13 0.064 CID_9543118 0.155 0.042 CID_123074 | ||
| 0.189 | 0.011 | 0.189 | Sphingosine 1-phosphate receptor 4 antagonist | 0.133 0.052 CID_439929 0.151 0.033 CID_9543118 0.165 0.022 CID_123074 | ||
| 0.183 | 0.005 | 0.183 | Lanosterol 14 alpha demethylase inhibitor | 0.132 0.02 CID_439929 0.132 0.02 CID_9543118 0.143 0.014 CID_123074 | ||
| 0.217 | 0.04 | 0.311 | Heat shock protein 90 alpha antagonist | 0.311 0.013 CID_439929 0.307 0.013 CID_9543118 0.298 0.015 CID_123074 | CID_439929 | |
| 0.186 | 0.01 | 0.186 | Electrolyte absorption antagonist | 0.114 0.041 CID_439929 0.114 0.041 CID_9543118 0.153 0.018 CID_123074 | ||
| 0.201 | 0.025 | 0.302 | DNA intercalator | 0.237 0.018 CID_439929 0.261 0.015 CID_9543118 0.302 0.012 CID_123074 | CID_123074 | |
| 0.279 | 0.104 | 0.313 | Antithrombotic | 0.313 0.08 CID_439929 0.304 0.085 CID_9543118 0.31 0.081 CID_123074 | CID_439929 | |
| 0.23 | 0.056 | 0.23 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.15 0.12 CID_439929 | ||
| 0.232 | 0.059 | 0.315 | DNA methylase inhibitor | 0.315 0.024 CID_439929 0.309 0.025 CID_9543118 0.302 0.027 CID_123074 | CID_439929 | |
| 0.186 | 0.015 | 0.369 | Estrogen antagonist | 0.369 0.005 CID_439929 0.341 0.005 CID_9543118 0.347 0.005 CID_123074 | CID_439929 | |
| 0.196 | 0.025 | 0.247 | Toll-Like receptor 2 antagonist | 0.247 0.009 CID_439929 0.247 0.009 CID_9543118 0.223 0.015 CID_123074 | CID_9543118 | |
| 0.187 | 0.017 | 0.233 | Protein kinase C gamma inhibitor | 0.233 0.009 CID_439929 0.214 0.011 CID_9543118 0.202 0.014 CID_123074 | CID_439929 | |
| 0.183 | 0.013 | 0.183 | Phosphodiesterase 7B inhibitor | |||
| 0.181 | 0.011 | 0.181 | Heat shock protein 70 antagonist | 0.179 0.012 CID_439929 0.179 0.012 CID_9543118 0.173 0.016 CID_123074 | ||
| 0.201 | 0.032 | 0.201 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.185 | 0.016 | 0.185 | Pregnane X receptor agonist | 0.175 0.022 CID_439929 0.156 0.043 CID_9543118 0.159 0.039 CID_123074 | ||
| 0.172 | 0.004 | 0.172 | Aconitate hydratase inhibitor | 0.099 0.009 CID_439929 0.099 0.009 CID_9543118 0.139 0.005 CID_123074 | ||
| 0.196 | 0.028 | 0.335 | Topoisomerase I inhibitor | 0.318 0.009 CID_439929 0.327 0.009 CID_9543118 0.335 0.008 CID_123074 | CID_123074 | |
| 0.171 | 0.004 | 0.171 | Granulocyte macrophage colony stimulating factor agonist | 0.166 0.004 CID_439929 0.166 0.004 CID_9543118 0.154 0.005 CID_123074 | ||
| 0.202 | 0.034 | 0.202 | Cyclin-dependent kinase 8 inhibitor | 0.133 0.099 CID_439929 0.144 0.086 CID_9543118 0.14 0.09 CID_123074 | ||
| 0.185 | 0.019 | 0.292 | Carbonic anhydrase III inhibitor | 0.275 0.007 CID_439929 0.292 0.006 CID_9543118 0.267 0.008 CID_123074 | CID_9543118 | |
| 0.204 | 0.039 | 0.324 | Melanin inhibitor | 0.27 0.026 CID_439929 0.324 0.019 CID_9543118 0.272 0.025 CID_123074 | CID_9543118 | |
| 0.259 | 0.094 | 0.488 | Lipoxygenase inhibitor | 0.458 0.025 CID_439929 0.488 0.02 CID_9543118 0.418 0.033 CID_123074 | CID_9543118 | |
| 0.181 | 0.016 | 0.181 | Papain-like protease (SARS coronavirus) inhibitor | 0.169 0.021 CID_439929 0.169 0.021 CID_9543118 0.134 0.054 CID_123074 | ||
| 0.179 | 0.016 | 0.179 | TRPA1 agonist | 0.15 0.031 CID_439929 0.15 0.031 CID_9543118 0.152 0.03 CID_123074 | ||
| 0.176 | 0.014 | 0.185 | Phosphofructokinase-1 inhibitor | 0.141 0.02 CID_439929 0.141 0.02 CID_9543118 0.185 0.013 CID_123074 | CID_123074 | |
| 0.194 | 0.034 | 0.492 | Topoisomerase II inhibitor | 0.464 0.008 CID_439929 0.476 0.007 CID_9543118 0.492 0.007 CID_123074 | CID_123074 | |
| 0.183 | 0.024 | 0.183 | Interleukin 1b antagonist | 0.146 0.043 CID_439929 0.162 0.032 CID_9543118 0.147 0.043 CID_123074 | ||
| 0.188 | 0.03 | 0.218 | Cholesterol synthesis inhibitor | 0.192 0.029 CID_439929 0.218 0.023 CID_9543118 0.207 0.025 CID_123074 | CID_9543118 | |
| 0.186 | 0.029 | 0.234 | Adenylate cyclase inhibitor | 0.181 0.03 CID_439929 0.234 0.021 CID_9543118 0.214 0.023 CID_123074 | CID_9543118 | |
| 0.182 | 0.026 | 0.182 | Aminopeptidase B inhibitor | 0.141 0.042 CID_439929 0.141 0.042 CID_9543118 0.175 0.028 CID_123074 | ||
| 0.195 | 0.039 | 0.195 | Activin receptor-like kinase 2 inhibitor | 0.123 0.093 CID_439929 0.138 0.077 CID_9543118 0.129 0.086 CID_123074 | ||
| 0.193 | 0.038 | 0.193 | Cyclin-dependent kinase 3 inhibitor | 0.149 0.098 CID_9543118 0.168 0.063 CID_123074 | ||
| 0.202 | 0.047 | 0.202 | Cytidine deaminase inhibitor | 0.123 0.097 CID_439929 0.112 0.111 CID_9543118 0.142 0.082 CID_123074 | ||
| 0.165 | 0.01 | 0.219 | Glutamate decarboxylase inhibitor | 0.189 0.008 CID_439929 0.212 0.006 CID_9543118 0.219 0.005 CID_123074 | CID_123074 | |
| 0.189 | 0.035 | 0.209 | Cell wall synthesis inhibitor | 0.209 0.027 CID_439929 0.192 0.033 CID_9543118 0.2 0.03 CID_123074 | CID_439929 | |
| 0.169 | 0.016 | 0.169 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.17 | 0.017 | 0.174 | DNA repair enzyme inhibitor | 0.155 0.027 CID_439929 0.174 0.016 CID_9543118 0.173 0.016 CID_123074 | CID_9543118 | |
| 0.192 | 0.039 | 0.288 | Catenin beta inhibitor | 0.274 0.008 CID_439929 0.256 0.01 CID_9543118 0.288 0.006 CID_123074 | CID_123074 | |
| 0.177 | 0.025 | 0.177 | Falcipain 3 inhibitor | 0.132 0.046 CID_439929 0.132 0.046 CID_9543118 0.129 0.048 CID_123074 | ||
| 0.161 | 0.011 | 0.161 | Histamine N-methyltransferase inhibitor | 0.114 0.034 CID_439929 0.128 0.025 CID_9543118 0.148 0.015 CID_123074 | ||
| 0.157 | 0.007 | 0.157 | Sphingosine 1-phosphate receptor 4 agonist | 0.099 0.026 CID_439929 0.099 0.026 CID_9543118 0.107 0.022 CID_123074 | ||
| 0.193 | 0.044 | 0.227 | Protein kinase stimulant | 0.19 0.045 CID_439929 0.227 0.033 CID_9543118 0.207 0.039 CID_123074 | CID_9543118 | |
| 0.169 | 0.02 | 0.381 | Topoisomerase II alpha inhibitor | 0.321 0.006 CID_439929 0.358 0.005 CID_9543118 0.381 0.005 CID_123074 | CID_123074 | |
| 0.197 | 0.048 | 0.197 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.155 | 0.006 | 0.168 | Glycine receptor agonist | 0.118 0.013 CID_439929 0.118 0.013 CID_9543118 0.168 0.005 CID_123074 | CID_123074 | |
| 0.157 | 0.008 | 0.157 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.097 0.015 CID_439929 0.097 0.015 CID_9543118 0.138 0.009 CID_123074 | ||
| 0.153 | 0.004 | 0.153 | Potassium channel intermediate-conductance Ca-activated blocker | 0.059 0.043 CID_439929 0.074 0.022 CID_9543118 0.1 0.009 CID_123074 | ||
| 0.191 | 0.043 | 0.292 | Heat shock protein 90 antagonist | 0.291 0.011 CID_439929 0.292 0.011 CID_9543118 0.289 0.012 CID_123074 | CID_9543118 | |
| 0.182 | 0.037 | 0.182 | Sodium channel (voltage-gated) blocker | 0.109 0.097 CID_123074 | ||
| 0.19 | 0.045 | 0.271 | Interferon gamma antagonist | 0.237 0.031 CID_439929 0.262 0.026 CID_9543118 0.271 0.025 CID_123074 | CID_123074 | |
| 0.152 | 0.007 | 0.152 | Glycine receptor antagonist | 0.129 0.014 CID_439929 0.109 0.025 CID_9543118 0.137 0.011 CID_123074 | ||
| 0.289 | 0.144 | 0.422 | Antibacterial | 0.422 0.067 CID_439929 0.397 0.078 CID_9543118 0.39 0.081 CID_123074 | CID_439929 | |
| 0.169 | 0.024 | 0.18 | Interleukin 8 antagonist | 0.18 0.019 CID_439929 0.18 0.019 CID_9543118 0.174 0.022 CID_123074 | CID_9543118 | |
| 0.199 | 0.054 | 0.199 | Tumour necrosis factor antagonist | 0.151 0.099 CID_439929 0.184 0.063 CID_9543118 0.181 0.066 CID_123074 | ||
| 0.264 | 0.12 | 0.406 | Prostaglandin dehydrogenase inhibitor | 0.406 0.065 CID_439929 0.395 0.068 CID_9543118 0.361 0.079 CID_123074 | CID_439929 | |
| 0.186 | 0.042 | 0.186 | Toll-Like receptor 9 antagonist | 0.113 0.094 CID_9543118 0.126 0.08 CID_123074 | ||
| 0.153 | 0.009 | 0.153 | Acyl-CoA dehydrogenase inhibitor | 0.078 0.023 CID_439929 0.078 0.023 CID_9543118 0.119 0.013 CID_123074 | ||
| 0.16 | 0.016 | 0.226 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.211 0.008 CID_439929 0.226 0.007 CID_9543118 0.217 0.008 CID_123074 | CID_9543118 | |
| 0.235 | 0.092 | 0.235 | Cardiotonic | |||
| 0.169 | 0.027 | 0.169 | GABA receptor agonist | 0.094 0.085 CID_439929 0.109 0.067 CID_9543118 0.124 0.053 CID_123074 | ||
| 0.157 | 0.015 | 0.159 | Glutamate dehydrogenase inhibitor | 0.113 0.025 CID_439929 0.113 0.025 CID_9543118 0.159 0.014 CID_123074 | CID_123074 | |
| 0.166 | 0.024 | 0.166 | Sphingosine 1-phosphate receptor 2 antagonist | 0.146 0.046 CID_439929 0.146 0.046 CID_9543118 0.154 0.036 CID_123074 | ||
| 0.159 | 0.018 | 0.274 | Protein kinase C zeta inhibitor | 0.274 0.006 CID_439929 0.223 0.009 CID_9543118 0.188 0.013 CID_123074 | CID_439929 | |
| 0.218 | 0.078 | 0.218 | MAP kinase kinase 3 inhibitor | 0.201 0.12 CID_123074 | ||
| 0.156 | 0.016 | 0.164 | CC chemokine 6 receptor antagonist | 0.14 0.04 CID_439929 0.15 0.022 CID_9543118 0.164 0.01 CID_123074 | CID_123074 | |
| 0.185 | 0.045 | 0.185 | Thiol protease inhibitor | 0.165 0.058 CID_439929 0.177 0.05 CID_9543118 0.183 0.046 CID_123074 | ||
| 0.144 | 0.005 | 0.144 | Glutamate (mGluR group II) agonist | |||
| 0.15 | 0.011 | 0.15 | Carbamoyl phosphate synthetase inhibitor | 0.103 0.02 CID_439929 0.103 0.02 CID_9543118 0.142 0.012 CID_123074 | ||
| 0.176 | 0.038 | 0.176 | MAP kinase 3 inhibitor | 0.133 0.099 CID_439929 0.136 0.093 CID_9543118 0.139 0.087 CID_123074 | ||
| 0.15 | 0.012 | 0.15 | Glutamate (mGluR7) agonist | 0.092 0.078 CID_439929 0.092 0.078 CID_9543118 0.11 0.043 CID_123074 | ||
| 0.18 | 0.042 | 0.18 | Nav1.2 sodium channel blocker | 0.116 0.088 CID_123074 | ||
| 0.16 | 0.022 | 0.16 | Nav1.5 sodium channel blocker | 0.108 0.071 CID_9543118 0.104 0.078 CID_123074 | ||
| 0.17 | 0.033 | 0.174 | Cyclooxygenase 3 inhibitor | 0.16 0.04 CID_439929 0.174 0.031 CID_9543118 0.174 0.031 CID_123074 | CID_123074 | |
| 0.147 | 0.011 | 0.147 | Protein kinase C alpha inhibitor | 0.098 0.023 CID_439929 0.076 0.038 CID_9543118 0.08 0.034 CID_123074 | ||
| 0.15 | 0.018 | 0.165 | Anabolic | 0.154 0.016 CID_439929 0.154 0.016 CID_9543118 0.165 0.011 CID_123074 | CID_123074 | |
| 0.137 | 0.005 | 0.137 | Glutamate (mGluR2) agonist | |||
| 0.137 | 0.004 | 0.137 | Glutamate (mGluR6) antagonist | 0.099 0.011 CID_439929 0.099 0.011 CID_9543118 0.114 0.006 CID_123074 | ||
| 0.136 | 0.004 | 0.136 | Phospholipase D inhibitor | 0.09 0.022 CID_439929 0.096 0.017 CID_9543118 0.11 0.01 CID_123074 | ||
| 0.152 | 0.022 | 0.152 | Transcription factor STAT6 inhibitor | 0.129 0.046 CID_439929 0.143 0.029 CID_9543118 0.149 0.024 CID_123074 | ||
| 0.197 | 0.067 | 0.197 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.167 | 0.036 | 0.167 | MAP kinase kinase 4 inhibitor | 0.14 0.085 CID_439929 0.156 0.051 CID_9543118 0.167 0.036 CID_123074 | ||
| 0.175 | 0.045 | 0.214 | Cyclooxygenase 1 inhibitor | 0.214 0.029 CID_439929 0.195 0.036 CID_9543118 0.167 0.049 CID_123074 | CID_439929 | |
| 0.198 | 0.068 | 0.198 | CDC-like kinase 2 inhibitor | |||
| 0.139 | 0.01 | 0.233 | GABA aminotransferase inhibitor | 0.157 0.007 CID_439929 0.197 0.004 CID_9543118 0.233 0.004 CID_123074 | CID_123074 | |
| 0.141 | 0.012 | 0.141 | Bromodomain-containing protein 2 inhibitor | 0.09 0.054 CID_439929 0.111 0.03 CID_9543118 0.118 0.024 CID_123074 | ||
| 0.141 | 0.012 | 0.141 | Argininosuccinate synthase inhibitor | 0.083 0.024 CID_439929 0.083 0.024 CID_9543118 0.133 0.013 CID_123074 | ||
| 0.174 | 0.046 | 0.174 | Cytokine production inhibitor | 0.135 0.074 CID_9543118 0.119 0.09 CID_123074 | ||
| 0.132 | 0.004 | 0.132 | Exportin-1 inhibitor | 0.075 0.032 CID_439929 0.083 0.022 CID_9543118 0.102 0.008 CID_123074 | ||
| 0.227 | 0.1 | 0.227 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.159 | 0.033 | 0.17 | Microtubule formation inhibitor | 0.17 0.029 CID_439929 0.147 0.039 CID_9543118 0.162 0.032 CID_123074 | CID_439929 | |
| 0.153 | 0.027 | 0.187 | Potassium channel (Ca-activated) activator | 0.134 0.034 CID_439929 0.184 0.018 CID_9543118 0.187 0.018 CID_123074 | CID_123074 | |
| 0.158 | 0.032 | 0.158 | MAP kinase 13 inhibitor | |||
| 0.241 | 0.115 | 0.241 | Ca(v)3.3 blocker | |||
| 0.178 | 0.053 | 0.178 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.133 | 0.009 | 0.155 | D-Ala-D-Ala ligase inhibitor | 0.155 0.005 CID_439929 0.155 0.005 CID_9543118 0.143 0.006 CID_123074 | CID_9543118 | |
| 0.136 | 0.012 | 0.136 | mTOR complex 2 inhibitor | 0.107 0.026 CID_439929 0.107 0.026 CID_9543118 0.113 0.021 CID_123074 | ||
| 0.13 | 0.006 | 0.237 | Topoisomerase II beta inhibitor | 0.237 0.003 CID_439929 0.219 0.004 CID_9543118 0.18 0.004 CID_123074 | CID_439929 | |
| 0.144 | 0.021 | 0.288 | Telomerase inhibitor | 0.183 0.016 CID_439929 0.288 0.007 CID_9543118 0.287 0.007 CID_123074 | CID_9543118 | |
| 0.127 | 0.004 | 0.127 | Glutamate (mGluR7) antagonist | 0.098 0.012 CID_439929 0.098 0.012 CID_9543118 0.113 0.005 CID_123074 | ||
| 0.163 | 0.04 | 0.163 | Nav1.3 sodium channel blocker | |||
| 0.132 | 0.01 | 0.132 | Potassium channel Kv1.5 blocker | |||
| 0.127 | 0.005 | 0.127 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.089 0.024 CID_439929 0.089 0.024 CID_9543118 0.097 0.015 CID_123074 | ||
| 0.162 | 0.041 | 0.216 | Alkylator | 0.192 0.029 CID_439929 0.198 0.027 CID_9543118 0.216 0.022 CID_123074 | CID_123074 | |
| 0.141 | 0.02 | 0.141 | Glutamate receptor agonist | |||
| 0.159 | 0.037 | 0.159 | Histone deacetylase class III inhibitor | |||
| 0.17 | 0.049 | 0.205 | Hemostatic | 0.205 0.031 CID_439929 0.202 0.032 CID_9543118 0.194 0.035 CID_123074 | CID_439929 | |
| 0.136 | 0.015 | 0.136 | Aminopeptidase I inhibitor | 0.098 0.029 CID_439929 0.098 0.029 CID_9543118 0.125 0.018 CID_123074 | ||
| 0.157 | 0.036 | 0.172 | Alpha 2b adrenoreceptor antagonist | 0.172 0.031 CID_439929 0.169 0.032 CID_9543118 0.158 0.035 CID_123074 | CID_439929 | |
| 0.124 | 0.003 | 0.124 | Alpha 1d adrenoreceptor agonist | 0.096 0.004 CID_439929 0.096 0.004 CID_9543118 0.096 0.004 CID_123074 | ||
| 0.145 | 0.024 | 0.145 | Calcium antagonist | 0.079 0.065 CID_123074 | ||
| 0.151 | 0.032 | 0.161 | Mucolytic | 0.156 0.029 CID_439929 0.161 0.027 CID_9543118 0.158 0.028 CID_123074 | CID_9543118 | |
| 0.129 | 0.01 | 0.157 | Purinergic P2X1 antagonist | 0.12 0.012 CID_439929 0.131 0.009 CID_9543118 0.157 0.006 CID_123074 | CID_123074 | |
| 0.175 | 0.057 | 0.175 | Diuretic | 0.135 0.09 CID_439929 0.148 0.079 CID_9543118 0.167 0.064 CID_123074 | ||
| 0.125 | 0.007 | 0.177 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.171 0.004 CID_439929 0.166 0.004 CID_9543118 0.177 0.004 CID_123074 | CID_123074 | |
| 0.14 | 0.023 | 0.219 | Carbonic anhydrase VI inhibitor | 0.219 0.011 CID_439929 0.219 0.011 CID_9543118 0.196 0.014 CID_123074 | CID_9543118 | |
| 0.153 | 0.037 | 0.431 | 5-Lipoxygenase inhibitor | 0.351 0.007 CID_439929 0.431 0.005 CID_9543118 0.377 0.006 CID_123074 | CID_9543118 | |
| 0.163 | 0.049 | 0.163 | Sodium channel blocker | |||
| 0.128 | 0.014 | 0.128 | Nicotinic alpha4beta2 receptor antagonist | 0.081 0.049 CID_123074 | ||
| 0.152 | 0.039 | 0.152 | Beta amyloid protein antagonist | 0.1 0.09 CID_9543118 0.104 0.085 CID_123074 | ||
| 0.123 | 0.01 | 0.123 | Acetylcholine M5 receptor agonist | 0.068 0.046 CID_123074 | ||
| 0.128 | 0.017 | 0.46 | CDC25A inhibitor | 0.46 0.003 CID_439929 0.366 0.003 CID_9543118 0.377 0.003 CID_123074 | CID_439929 | |
| 0.162 | 0.05 | 0.176 | Interleukin 1 antagonist | 0.141 0.065 CID_439929 0.176 0.044 CID_9543118 0.14 0.065 CID_123074 | CID_9543118 | |
| 0.12 | 0.01 | 0.136 | Estrogen-related receptor beta agonist | 0.125 0.008 CID_439929 0.125 0.008 CID_9543118 0.136 0.005 CID_123074 | CID_123074 | |
| 0.195 | 0.086 | 0.195 | Anticonvulsant | |||
| 0.118 | 0.009 | 0.118 | 5 Hydroxytryptamine 3 agonist | 0.059 0.05 CID_439929 0.064 0.042 CID_9543118 0.085 0.023 CID_123074 | ||
| 0.145 | 0.036 | 0.273 | Xanthine oxidase inhibitor | 0.273 0.01 CID_439929 0.261 0.011 CID_9543118 0.221 0.016 CID_123074 | CID_439929 | |
| 0.176 | 0.068 | 0.176 | Antipruritic | 0.137 0.111 CID_9543118 0.161 0.083 CID_123074 | ||
| 0.171 | 0.062 | 0.358 | Protein-tyrosine phosphatase inhibitor | 0.349 0.012 CID_439929 0.358 0.011 CID_9543118 0.341 0.013 CID_123074 | CID_9543118 | |
| 0.128 | 0.019 | 0.128 | Phosphodiesterase 6D inhibitor | 0.117 0.027 CID_439929 0.117 0.027 CID_9543118 0.109 0.037 CID_123074 | ||
| 0.172 | 0.063 | 0.172 | Polo-like kinase-3 inhibitor | |||
| 0.155 | 0.047 | 0.159 | Anesthetic local | 0.144 0.052 CID_439929 0.147 0.05 CID_9543118 0.159 0.045 CID_123074 | CID_123074 | |
| 0.116 | 0.008 | 0.179 | CD45 antagonist | 0.106 0.009 CID_439929 0.179 0.005 CID_9543118 0.16 0.005 CID_123074 | CID_9543118 | |
| 0.116 | 0.009 | 0.137 | GABA B receptor agonist | 0.121 0.007 CID_439929 0.137 0.005 CID_9543118 0.132 0.005 CID_123074 | CID_9543118 | |
| 0.111 | 0.004 | 0.191 | Dopamine D5 agonist | 0.191 0.002 CID_439929 0.191 0.002 CID_9543118 0.182 0.002 CID_123074 | CID_9543118 | |
| 0.141 | 0.034 | 0.207 | AMP-activated protein kinase stimulant | 0.207 0.01 CID_439929 0.199 0.011 CID_9543118 0.177 0.015 CID_123074 | CID_439929 | |
| 0.11 | 0.004 | 0.11 | Purinergic P2Y14 antagonist | 0.031 0.02 CID_439929 | ||
| 0.16 | 0.054 | 0.16 | Histone deacetylase SIRT1 inhibitor | 0.117 0.095 CID_9543118 0.109 0.106 CID_123074 | ||
| 0.115 | 0.009 | 0.115 | Vanilloid 4 agonist | 0.079 0.043 CID_439929 0.079 0.043 CID_9543118 0.097 0.019 CID_123074 | ||
| 0.113 | 0.007 | 0.113 | Potassium channel (Ca-activated) blocker | |||
| 0.159 | 0.054 | 0.195 | Alkaline phosphatase inhibitor | 0.195 0.035 CID_439929 0.182 0.041 CID_9543118 0.159 0.054 CID_123074 | CID_439929 | |
| 0.115 | 0.01 | 0.115 | CC chemokine 5 receptor agonist | 0.097 0.025 CID_439929 0.097 0.025 CID_9543118 0.105 0.016 CID_123074 | ||
| 0.158 | 0.054 | 0.158 | Neuropeptide Y1 antagonist | 0.138 0.084 CID_123074 | ||
| 0.13 | 0.027 | 0.13 | MAP kinase kinase 1 inhibitor | 0.116 0.038 CID_439929 0.117 0.038 CID_9543118 0.127 0.029 CID_123074 | ||
| 0.13 | 0.027 | 0.133 | Interleukin 1 beta converting enzyme inhibitor | 0.112 0.043 CID_439929 0.127 0.029 CID_9543118 0.133 0.026 CID_123074 | CID_123074 | |
| 0.133 | 0.03 | 0.223 | Uric acid excretion stimulant | 0.179 0.016 CID_439929 0.223 0.01 CID_9543118 0.216 0.011 CID_123074 | CID_9543118 | |
| 0.118 | 0.015 | 0.118 | I kappa B kinase 1 inhibitor | |||
| 0.107 | 0.005 | 0.107 | Corticotropin releasing factor 2 receptor antagonist | 0.058 0.052 CID_439929 0.069 0.03 CID_9543118 0.082 0.016 CID_123074 | ||
| 0.108 | 0.006 | 0.108 | Nicotinic alpha3beta2 receptor antagonist | 0.055 0.033 CID_439929 0.055 0.033 CID_9543118 0.065 0.021 CID_123074 | ||
| 0.122 | 0.021 | 0.154 | Keratolytic | 0.151 0.014 CID_439929 0.151 0.014 CID_9543118 0.154 0.014 CID_123074 | CID_123074 | |
| 0.14 | 0.039 | 0.238 | Expectorant | 0.238 0.014 CID_439929 0.207 0.019 CID_9543118 0.199 0.021 CID_123074 | CID_439929 | |
| 0.114 | 0.013 | 0.114 | Carbonic anhydrase VB inhibitor | 0.095 0.017 CID_439929 0.101 0.016 CID_9543118 0.089 0.019 CID_123074 | ||
| 0.119 | 0.02 | 0.127 | Myeloperoxidase inhibitor | 0.127 0.017 CID_439929 0.127 0.017 CID_9543118 0.122 0.019 CID_123074 | CID_9543118 | |
| 0.117 | 0.017 | 0.117 | Histone deacetylase SIRT2 inhibitor | |||
| 0.12 | 0.021 | 0.12 | Carbonic anhydrase V inhibitor | 0.101 0.027 CID_439929 0.105 0.025 CID_9543118 0.094 0.029 CID_123074 | ||
| 0.144 | 0.045 | 0.156 | Vanilloid 1 agonist | 0.152 0.036 CID_439929 0.156 0.033 CID_9543118 0.152 0.037 CID_123074 | CID_9543118 | |
| 0.121 | 0.024 | 0.121 | GABA A receptor agonist | 0.088 0.05 CID_123074 | ||
| 0.101 | 0.005 | 0.101 | Calcium channel P-type blocker | 0.07 0.028 CID_439929 0.078 0.017 CID_9543118 0.082 0.013 CID_123074 | ||
| 0.1 | 0.004 | 0.1 | Acid-sensing ion channel blocker | 0.045 0.021 CID_439929 0.057 0.011 CID_9543118 0.057 0.011 CID_123074 | ||
| 0.101 | 0.005 | 0.101 | DNA helicase inhibitor | 0.068 0.019 CID_439929 0.083 0.01 CID_9543118 0.086 0.009 CID_123074 | ||
| 0.197 | 0.101 | 0.324 | Antiamyloidogenic | 0.3 0.052 CID_439929 0.324 0.045 CID_9543118 0.264 0.065 CID_123074 | CID_9543118 | |
| 0.123 | 0.028 | 0.19 | Carbonic anhydrase XIII inhibitor | 0.176 0.017 CID_439929 0.19 0.015 CID_9543118 0.166 0.019 CID_123074 | CID_9543118 | |
| 0.114 | 0.019 | 0.114 | Interferon agonist | 0.078 0.055 CID_439929 0.088 0.041 CID_9543118 0.11 0.022 CID_123074 | ||
| 0.12 | 0.025 | 0.167 | Macrophage migration inhibitory factor inhibitor | 0.159 0.013 CID_439929 0.167 0.012 CID_9543118 0.139 0.019 CID_123074 | CID_9543118 | |
| 0.099 | 0.004 | 0.099 | Adenylate cyclase 1 inhibitor | 0.066 0.014 CID_439929 0.066 0.014 CID_9543118 0.085 0.006 CID_123074 | ||
| 0.125 | 0.031 | 0.131 | Androgen antagonist | 0.131 0.028 CID_439929 0.122 0.032 CID_9543118 0.13 0.029 CID_123074 | CID_439929 | |
| 0.134 | 0.041 | 0.137 | Alpha 2c adrenoreceptor antagonist | 0.135 0.04 CID_439929 0.137 0.038 CID_9543118 0.131 0.042 CID_123074 | CID_9543118 | |
| 0.112 | 0.019 | 0.112 | Caspase 7 inhibitor | 0.082 0.057 CID_439929 0.094 0.035 CID_9543118 0.102 0.026 CID_123074 | ||
| 0.106 | 0.014 | 0.106 | NMDA receptor glycine site agonist | 0.063 0.043 CID_439929 0.063 0.043 CID_9543118 0.09 0.022 CID_123074 | ||
| 0.119 | 0.027 | 0.119 | Ornithine decarboxylase inhibitor | 0.108 0.036 CID_439929 0.113 0.031 CID_9543118 0.117 0.028 CID_123074 | ||
| 0.099 | 0.007 | 0.099 | 5 Hydroxytryptamine 7 agonist | 0.061 0.029 CID_439929 0.071 0.018 CID_9543118 0.073 0.017 CID_123074 | ||
| 0.104 | 0.012 | 0.122 | Protein kinase C beta inhibitor | 0.122 0.007 CID_439929 0.109 0.01 CID_9543118 0.113 0.009 CID_123074 | CID_439929 | |
| 0.113 | 0.021 | 0.257 | Estrogen receptor alpha antagonist | 0.257 0.006 CID_439929 0.242 0.006 CID_9543118 0.182 0.009 CID_123074 | CID_439929 | |
| 0.126 | 0.034 | 0.126 | Nitric-oxide synthase inhibitor | 0.086 0.084 CID_439929 0.089 0.079 CID_9543118 0.099 0.061 CID_123074 | ||
| 0.105 | 0.013 | 0.106 | Alpha 2 adrenoreceptor agonist | 0.102 0.014 CID_439929 0.106 0.013 CID_9543118 0.104 0.013 CID_123074 | CID_9543118 | |
| 0.158 | 0.067 | 0.159 | Acetylcholine M1 receptor antagonist | 0.159 0.066 CID_439929 0.142 0.083 CID_9543118 0.153 0.072 CID_123074 | CID_439929 | |
| 0.118 | 0.027 | 0.118 | Acetylcholine nicotinic agonist | |||
| 0.095 | 0.005 | 0.095 | Glucose-6-phosphate isomerase inhibitor | 0.076 0.01 CID_439929 0.076 0.01 CID_9543118 0.094 0.005 CID_123074 | ||
| 0.135 | 0.046 | 0.242 | MAO A inhibitor | 0.165 0.037 CID_439929 0.242 0.022 CID_9543118 0.213 0.027 CID_123074 | CID_9543118 | |
| 0.205 | 0.117 | 0.267 | Immunostimulant | 0.254 0.095 CID_439929 0.242 0.1 CID_9543118 0.267 0.089 CID_123074 | CID_123074 | |
| 0.114 | 0.026 | 0.114 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.1 | 0.013 | 0.114 | MAP kinase kinase 7 inhibitor | 0.099 0.014 CID_439929 0.106 0.009 CID_9543118 0.114 0.005 CID_123074 | CID_123074 | |
| 0.114 | 0.026 | 0.114 | Bile acid receptor antagonist | 0.111 0.029 CID_439929 0.114 0.025 CID_9543118 0.113 0.027 CID_123074 | ||
| 0.172 | 0.084 | 0.172 | TRKC antagonist | |||
| 0.126 | 0.039 | 0.143 | Urease inhibitor | 0.139 0.029 CID_439929 0.143 0.027 CID_9543118 0.136 0.031 CID_123074 | CID_9543118 | |
| 0.137 | 0.051 | 0.137 | MAP kinase 12 inhibitor | |||
| 0.126 | 0.04 | 0.182 | Beta glucuronidase inhibitor | 0.171 0.017 CID_439929 0.182 0.015 CID_9543118 0.168 0.018 CID_123074 | CID_9543118 | |
| 0.107 | 0.022 | 0.107 | Carbonic anhydrase VA inhibitor | 0.092 0.029 CID_439929 0.095 0.027 CID_9543118 0.088 0.031 CID_123074 | ||
| 0.097 | 0.012 | 0.143 | Fatty acid synthase inhibitor | 0.113 0.008 CID_439929 0.143 0.005 CID_9543118 0.12 0.007 CID_123074 | CID_9543118 | |
| 0.1 | 0.016 | 0.1 | NMDA 2C receptor antagonist | 0.068 0.035 CID_439929 0.072 0.031 CID_9543118 0.09 0.02 CID_123074 | ||
| 0.144 | 0.06 | 0.166 | Toll-Like receptor antagonist | 0.14 0.063 CID_439929 0.166 0.045 CID_9543118 0.157 0.051 CID_123074 | CID_9543118 | |
| 0.154 | 0.07 | 0.154 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.112 | 0.028 | 0.145 | Glutathione S-transferase inhibitor | 0.145 0.013 CID_439929 0.13 0.018 CID_9543118 0.124 0.021 CID_123074 | CID_439929 | |
| 0.145 | 0.062 | 0.215 | MAO inhibitor | 0.152 0.059 CID_439929 0.215 0.036 CID_9543118 0.193 0.043 CID_123074 | CID_9543118 | |
| 0.099 | 0.016 | 0.099 | Protease 3C (Human rhinovirus) inhibitor | 0.061 0.051 CID_439929 0.07 0.037 CID_9543118 0.083 0.025 CID_123074 | ||
| 0.095 | 0.012 | 0.188 | Estrogen receptor beta agonist | 0.188 0.005 CID_439929 0.172 0.005 CID_9543118 0.171 0.005 CID_123074 | CID_439929 | |
| 0.104 | 0.021 | 0.104 | Nav1.7 sodium channel blocker | |||
| 0.092 | 0.01 | 0.092 | MDM2 inhibitor | 0.067 0.048 CID_439929 0.068 0.043 CID_9543118 0.076 0.025 CID_123074 | ||
| 0.092 | 0.011 | 0.092 | Glutamate (mGluR group III) agonist | 0.038 0.036 CID_439929 0.038 0.036 CID_9543118 0.054 0.021 CID_123074 | ||
| 0.086 | 0.005 | 0.086 | Immunoglobulin Fc receptor antagonist | 0.063 0.019 CID_439929 0.063 0.019 CID_9543118 0.066 0.015 CID_123074 | ||
| 0.139 | 0.058 | 0.139 | Glutamate receptor antagonist | |||
| 0.091 | 0.01 | 0.094 | Transcription factor RelA inhibitor | 0.094 0.008 CID_439929 0.094 0.008 CID_9543118 0.088 0.011 CID_123074 | CID_9543118 | |
| 0.108 | 0.027 | 0.108 | Phosphodiesterase 3A inhibitor | |||
| 0.091 | 0.01 | 0.091 | Sphingosine kinase 2 inhibitor | 0.083 0.014 CID_439929 0.083 0.014 CID_9543118 0.077 0.017 CID_123074 | ||
| 0.138 | 0.058 | 0.16 | Antibacterial (Helicobacter pylori) | 0.16 0.039 CID_439929 0.156 0.041 CID_9543118 0.159 0.04 CID_123074 | CID_439929 | |
| 0.087 | 0.007 | 0.087 | Glutamate (mGluR4) antagonist | 0.042 0.033 CID_439929 0.052 0.019 CID_9543118 0.065 0.012 CID_123074 | ||
| 0.128 | 0.049 | 0.133 | Caspase 3 inhibitor | 0.112 0.073 CID_439929 0.126 0.052 CID_9543118 0.133 0.043 CID_123074 | CID_123074 | |
| 0.084 | 0.005 | 0.084 | GABA uptake inhibitor | 0.055 0.012 CID_439929 0.062 0.009 CID_9543118 0.075 0.006 CID_123074 | ||
| 0.099 | 0.019 | 0.099 | NMDA receptor agonist | 0.056 0.053 CID_439929 0.056 0.053 CID_9543118 0.082 0.027 CID_123074 | ||
| 0.084 | 0.005 | 0.084 | Sirtuin 2 inhibitor | 0.044 0.015 CID_439929 0.058 0.01 CID_9543118 0.064 0.009 CID_123074 | ||
| 0.096 | 0.017 | 0.096 | 5 Hydroxytryptamine 5A antagonist | 0.086 0.02 CID_439929 0.07 0.031 CID_9543118 0.07 0.031 CID_123074 | ||
| 0.095 | 0.016 | 0.095 | 5 Hydroxytryptamine 2A agonist | 0.055 0.053 CID_9543118 0.074 0.033 CID_123074 | ||
| 0.094 | 0.016 | 0.094 | Aryl hydrocarbon receptor antagonist | 0.064 0.046 CID_439929 0.076 0.031 CID_9543118 0.08 0.027 CID_123074 | ||
| 0.109 | 0.03 | 0.109 | Inducible nitric-oxide synthase inhibitor | 0.09 0.048 CID_439929 0.086 0.053 CID_9543118 0.094 0.042 CID_123074 | ||
| 0.086 | 0.008 | 0.097 | Dihydroorotate oxidase inhibitor | 0.08 0.011 CID_439929 0.092 0.006 CID_9543118 0.097 0.005 CID_123074 | CID_123074 | |
| 0.13 | 0.052 | 0.13 | 5 Hydroxytryptamine 2B antagonist | 0.099 0.085 CID_123074 | ||
| 0.1 | 0.022 | 0.522 | Beta tubulin antagonist | 0.522 0.004 CID_439929 0.289 0.005 CID_9543118 0.241 0.005 CID_123074 | CID_439929 | |
| 0.082 | 0.005 | 0.089 | Pregnane X receptor antagonist | 0.068 0.016 CID_439929 0.076 0.009 CID_9543118 0.089 0.004 CID_123074 | CID_123074 | |
| 0.107 | 0.031 | 0.125 | ATPase (Vacuolar H+) inhibitor | 0.109 0.029 CID_439929 0.125 0.017 CID_9543118 0.119 0.02 CID_123074 | CID_9543118 | |
| 0.102 | 0.025 | 0.13 | Leukotriene synthesis inhibitor | 0.119 0.017 CID_439929 0.13 0.014 CID_9543118 0.127 0.014 CID_123074 | CID_9543118 | |
| 0.114 | 0.037 | 0.114 | Potassium channel (Voltage-sensitive) activator | |||
| 0.083 | 0.007 | 0.083 | Retinoid X alpha receptor agonist | 0.043 0.018 CID_439929 0.061 0.011 CID_9543118 0.077 0.008 CID_123074 | ||
| 0.11 | 0.034 | 0.11 | Phosphodiesterase I inhibitor | 0.091 0.058 CID_439929 0.086 0.065 CID_9543118 0.088 0.061 CID_123074 | ||
| 0.09 | 0.014 | 0.09 | Phosphodiesterase 1C inhibitor | 0.074 0.025 CID_439929 0.078 0.021 CID_9543118 0.081 0.019 CID_123074 | ||
| 0.083 | 0.007 | 0.083 | Glutamate (mGluR group III) antagonist | 0.043 0.031 CID_439929 0.052 0.019 CID_9543118 0.064 0.011 CID_123074 | ||
| 0.085 | 0.01 | 0.085 | Aldosterone antagonist | 0.06 0.019 CID_123074 | ||
| 0.08 | 0.005 | 0.086 | Geranyltranstransferase inhibitor | 0.071 0.007 CID_439929 0.077 0.005 CID_9543118 0.086 0.004 CID_123074 | CID_123074 | |
| 0.15 | 0.074 | 0.172 | Phospholipase A2 inhibitor | 0.146 0.078 CID_439929 0.172 0.058 CID_9543118 0.167 0.061 CID_123074 | CID_9543118 | |
| 0.104 | 0.028 | 0.11 | Na+ K+ transporting ATPase inhibitor | 0.104 0.028 CID_439929 0.105 0.027 CID_9543118 0.11 0.023 CID_123074 | CID_123074 | |
| 0.144 | 0.069 | 0.144 | Ribosomal protein S6 kinase inhibitor | |||
| 0.079 | 0.004 | 0.079 | Glutamate (mGluR1a) agonist | 0.022 0.015 CID_439929 0.022 0.015 CID_9543118 0.042 0.005 CID_123074 | ||
| 0.093 | 0.019 | 0.308 | Estrogen agonist | 0.308 0.005 CID_439929 0.271 0.005 CID_9543118 0.269 0.005 CID_123074 | CID_439929 | |
| 0.085 | 0.011 | 0.087 | Potassium channel Kv1.3 blocker | 0.052 0.027 CID_439929 0.066 0.017 CID_9543118 0.087 0.01 CID_123074 | CID_123074 | |
| 0.091 | 0.017 | 0.091 | 5 Hydroxytryptamine 5 antagonist | 0.077 0.022 CID_439929 0.063 0.033 CID_9543118 0.062 0.034 CID_123074 | ||
| 0.098 | 0.025 | 0.098 | Transforming growth factor beta 3 antagonist | |||
| 0.083 | 0.009 | 0.083 | Prolactin release inhibitor | 0.066 0.032 CID_439929 0.066 0.032 CID_9543118 0.068 0.026 CID_123074 | ||
| 0.129 | 0.056 | 0.291 | Monophenol monooxygenase inhibitor | 0.242 0.025 CID_439929 0.291 0.019 CID_9543118 0.242 0.025 CID_123074 | CID_9543118 | |
| 0.137 | 0.064 | 0.269 | Interleukin 4 antagonist | 0.269 0.011 CID_439929 0.207 0.02 CID_9543118 0.147 0.052 CID_123074 | CID_439929 | |
| 0.144 | 0.071 | 0.144 | Vascular endothelial growth factor 3 antagonist | |||
| 0.1 | 0.028 | 0.104 | Alpha adrenoreceptor agonist | 0.096 0.029 CID_439929 0.104 0.026 CID_9543118 0.097 0.029 CID_123074 | CID_9543118 | |
| 0.081 | 0.009 | 0.119 | Squalene epoxidase inhibitor | 0.119 0.004 CID_439929 0.094 0.006 CID_9543118 0.082 0.009 CID_123074 | CID_439929 | |
| 0.089 | 0.017 | 0.089 | Potassium channel (Tandem pore domain) blocker | |||
| 0.076 | 0.004 | 0.076 | Nerve growth factor antagonist | 0.056 0.012 CID_439929 0.056 0.012 CID_9543118 0.056 0.012 CID_123074 | ||
| 0.089 | 0.018 | 0.089 | Interferon inducer | 0.06 0.053 CID_439929 0.064 0.045 CID_9543118 0.082 0.022 CID_123074 | ||
| 0.087 | 0.016 | 0.164 | Heat shock protein 90 beta antagonist | 0.164 0.004 CID_439929 0.157 0.004 CID_9543118 0.16 0.004 CID_123074 | CID_439929 | |
| 0.084 | 0.014 | 0.084 | Glucosylceramidase inhibitor | 0.057 0.034 CID_439929 0.059 0.033 CID_9543118 0.069 0.023 CID_123074 | ||
| 0.089 | 0.019 | 0.098 | Androgen agonist | 0.091 0.018 CID_439929 0.079 0.024 CID_9543118 0.098 0.015 CID_123074 | CID_123074 | |
| 0.084 | 0.014 | 0.084 | 5 Hydroxytryptamine 2 agonist | 0.053 0.034 CID_123074 | ||
| 0.091 | 0.021 | 0.091 | Carbonic anhydrase stimulant | 0.057 0.043 CID_439929 0.057 0.043 CID_9543118 0.058 0.043 CID_123074 | ||
| 0.142 | 0.072 | 0.142 | Glycogen synthase kinase-3 alpha inhibitor | 0.114 0.089 CID_9543118 0.104 0.1 CID_123074 | ||
| 0.078 | 0.01 | 0.078 | Ryanodine receptor antagonist | 0.072 0.015 CID_439929 0.072 0.015 CID_9543118 0.076 0.011 CID_123074 | ||
| 0.158 | 0.089 | 0.18 | Death-associated protein kinase 2 inhibitor | 0.18 0.054 CID_439929 0.18 0.054 CID_9543118 0.144 0.12 CID_123074 | CID_9543118 | |
| 0.096 | 0.028 | 0.096 | Benzodiazepine agonist | |||
| 0.201 | 0.132 | 0.333 | Streptokinase A inhibitor | 0.263 0.095 CID_439929 0.3 0.079 CID_9543118 0.333 0.067 CID_123074 | CID_123074 | |
| 0.118 | 0.05 | 0.118 | Nav1.1 sodium channel blocker | |||
| 0.091 | 0.024 | 0.091 | Secretase beta inhibitor | |||
| 0.072 | 0.004 | 0.072 | Melatonin receptor 1A agonist | 0.036 0.019 CID_439929 0.036 0.019 CID_9543118 0.035 0.02 CID_123074 | ||
| 0.071 | 0.004 | 0.071 | Histamine H1 receptor agonist | 0.048 0.021 CID_123074 | ||
| 0.079 | 0.012 | 0.079 | Alpha-mannosidase inhibitor | 0.061 0.026 CID_439929 0.061 0.026 CID_9543118 0.076 0.013 CID_123074 | ||
| 0.074 | 0.008 | 0.074 | Fumarate hydratase inhibitor | 0.044 0.016 CID_439929 0.044 0.016 CID_9543118 0.066 0.009 CID_123074 | ||
| 0.124 | 0.058 | 0.124 | Calcium channel N-type blocker | |||
| 0.076 | 0.011 | 0.076 | Lysophosphatidic acid 3 receptor antagonist | 0.055 0.029 CID_439929 0.059 0.024 CID_9543118 0.062 0.02 CID_123074 | ||
| 0.073 | 0.007 | 0.073 | Dopamine beta hydroxylase inhibitor | 0.069 0.008 CID_439929 0.069 0.008 CID_9543118 0.07 0.008 CID_123074 | ||
| 0.074 | 0.009 | 0.074 | Retinoid X receptor agonist | 0.06 0.014 CID_439929 0.059 0.014 CID_9543118 0.071 0.01 CID_123074 | ||
| 0.07 | 0.005 | 0.07 | Guanylate cyclase inhibitor | 0.055 0.016 CID_439929 0.055 0.016 CID_9543118 0.065 0.008 CID_123074 | ||
| 0.129 | 0.064 | 0.448 | M18 aspartyl aminopeptidase inhibitor | 0.448 0.004 CID_439929 0.434 0.004 CID_9543118 0.367 0.006 CID_123074 | CID_439929 | |
| 0.078 | 0.013 | 0.078 | Lysine-specific demethylase 1A inhibitor | 0.054 0.037 CID_439929 0.057 0.032 CID_9543118 0.052 0.042 CID_123074 | ||
| 0.114 | 0.049 | 0.114 | Gastric antisecretory | |||
| 0.076 | 0.011 | 0.076 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.082 | 0.018 | 0.097 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.097 0.011 CID_439929 0.092 0.013 CID_9543118 0.082 0.018 CID_123074 | CID_439929 | |
| 0.13 | 0.065 | 0.13 | MAP kinase kinase inhibitor | 0.101 0.094 CID_9543118 0.12 0.074 CID_123074 | ||
| 0.069 | 0.005 | 0.084 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.066 0.005 CID_439929 0.066 0.005 CID_9543118 0.084 0.004 CID_123074 | CID_123074 | |
| 0.074 | 0.01 | 0.074 | Fructose-1,6-bisphosphatase inhibitor | 0.042 0.036 CID_439929 0.042 0.036 CID_9543118 0.048 0.026 CID_123074 | ||
| 0.086 | 0.023 | 0.328 | CDC25B inhibitor | 0.308 0.004 CID_439929 0.328 0.004 CID_9543118 0.328 0.004 CID_123074 | CID_123074 | |
| 0.081 | 0.017 | 0.081 | Cyclin D1 inhibitor | 0.058 0.047 CID_439929 0.058 0.047 CID_9543118 0.067 0.033 CID_123074 | ||
| 0.073 | 0.01 | 0.073 | Dihydroorotase inhibitor | 0.054 0.02 CID_439929 0.065 0.014 CID_9543118 0.056 0.019 CID_123074 | ||
| 0.066 | 0.003 | 0.066 | Imidazoline I1 receptor antagonist | 0.021 0.014 CID_439929 0.025 0.009 CID_9543118 0.03 0.007 CID_123074 | ||
| 0.106 | 0.044 | 0.125 | Alpha 2 adrenoreceptor antagonist | 0.123 0.035 CID_439929 0.125 0.035 CID_9543118 0.108 0.042 CID_123074 | CID_9543118 | |
| 0.083 | 0.02 | 0.083 | Ornithine carbamoyltransferase inhibitor | 0.048 0.041 CID_439929 0.048 0.041 CID_9543118 0.07 0.026 CID_123074 | ||
| 0.07 | 0.007 | 0.07 | Benzodiazepine antagonist | 0.049 0.028 CID_439929 0.046 0.035 CID_9543118 0.048 0.031 CID_123074 | ||
| 0.099 | 0.037 | 0.146 | Alpha 2a adrenoreceptor antagonist | 0.146 0.023 CID_439929 0.142 0.024 CID_9543118 0.112 0.032 CID_123074 | CID_439929 | |
| 0.081 | 0.019 | 0.081 | NMDA 2A receptor antagonist | 0.054 0.034 CID_439929 0.062 0.028 CID_9543118 0.074 0.022 CID_123074 | ||
| 0.091 | 0.029 | 0.091 | Amidase inhibitor | 0.07 0.049 CID_9543118 | ||
| 0.124 | 0.062 | 0.124 | Proteasome inhibitor | 0.105 0.08 CID_9543118 0.106 0.079 CID_123074 | ||
| 0.07 | 0.008 | 0.07 | GABA B receptor antagonist | 0.055 0.015 CID_439929 0.061 0.012 CID_9543118 0.069 0.009 CID_123074 | ||
| 0.068 | 0.007 | 0.068 | Diamine oxidase inhibitor | |||
| 0.095 | 0.034 | 0.137 | Thioredoxin reductase inhibitor | 0.137 0.012 CID_439929 0.118 0.018 CID_9543118 0.123 0.016 CID_123074 | CID_439929 | |
| 0.092 | 0.031 | 0.092 | Prostaglandin-E synthase inhibitor | 0.075 0.043 CID_439929 0.09 0.033 CID_9543118 0.086 0.035 CID_123074 | ||
| 0.078 | 0.017 | 0.078 | Phosphodiesterase 1A inhibitor | |||
| 0.07 | 0.009 | 0.07 | Purinergic P2X4 antagonist | 0.055 0.018 CID_439929 0.055 0.018 CID_9543118 0.052 0.022 CID_123074 | ||
| 0.065 | 0.005 | 0.065 | Kainate receptor agonist | 0.051 0.013 CID_439929 0.051 0.013 CID_9543118 0.059 0.007 CID_123074 | ||
| 0.075 | 0.015 | 0.075 | Epithelial sodium channel blocker | 0.05 0.048 CID_439929 0.054 0.039 CID_9543118 0.057 0.033 CID_123074 | ||
| 0.063 | 0.003 | 0.063 | Alpha 2a adrenoreceptor agonist | 0.037 0.005 CID_439929 0.055 0.004 CID_9543118 0.046 0.004 CID_123074 | ||
| 0.088 | 0.028 | 0.103 | Elastase 1 inhibitor | 0.103 0.019 CID_439929 0.103 0.019 CID_9543118 0.084 0.031 CID_123074 | CID_9543118 | |
| 0.075 | 0.015 | 0.075 | Potassium channel (Inward rectifier) blocker | |||
| 0.071 | 0.011 | 0.075 | Thymidylate synthase inhibitor | 0.055 0.022 CID_439929 0.063 0.015 CID_9543118 0.075 0.009 CID_123074 | CID_123074 | |
| 0.068 | 0.008 | 0.068 | Cytokine production stimulant | 0.05 0.03 CID_123074 | ||
| 0.079 | 0.02 | 0.079 | Bombesin 3 receptor antagonist | 0.051 0.046 CID_123074 | ||
| 0.081 | 0.022 | 0.081 | Phosphodiesterase 1B inhibitor | |||
| 0.069 | 0.011 | 0.069 | Histamine H2 receptor agonist | |||
| 0.078 | 0.019 | 0.078 | Nicotinic alpha7 receptor agonist | |||
| 0.084 | 0.026 | 0.131 | Aromatase inhibitor | 0.117 0.018 CID_439929 0.131 0.016 CID_9543118 0.123 0.017 CID_123074 | CID_9543118 | |
| 0.082 | 0.024 | 0.136 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.104 0.016 CID_439929 0.136 0.009 CID_9543118 0.112 0.014 CID_123074 | CID_9543118 | |
| 0.064 | 0.006 | 0.064 | Glutamate (mGluR8) agonist | 0.052 0.01 CID_439929 0.052 0.01 CID_9543118 0.06 0.007 CID_123074 | ||
| 0.085 | 0.027 | 0.085 | Orexin receptor 1 antagonist | |||
| 0.093 | 0.036 | 0.093 | Cathepsin G inhibitor | 0.064 0.062 CID_439929 0.083 0.042 CID_9543118 0.091 0.037 CID_123074 | ||
| 0.081 | 0.023 | 0.155 | Protein kinase C eta inhibitor | 0.155 0.007 CID_439929 0.114 0.014 CID_9543118 0.121 0.012 CID_123074 | CID_439929 | |
| 0.076 | 0.019 | 0.076 | Sphingosine kinase inhibitor | 0.07 0.024 CID_439929 0.075 0.02 CID_9543118 0.072 0.023 CID_123074 | ||
| 0.071 | 0.013 | 0.238 | Estrogen receptor alpha agonist | 0.238 0.004 CID_439929 0.163 0.005 CID_9543118 0.169 0.005 CID_123074 | CID_439929 | |
| 0.069 | 0.012 | 0.069 | Heparanase inhibitor | 0.057 0.029 CID_439929 0.059 0.024 CID_9543118 0.062 0.019 CID_123074 | ||
| 0.064 | 0.007 | 0.064 | Glutamate (mGluR3) antagonist | 0.038 0.023 CID_439929 0.04 0.021 CID_9543118 0.048 0.014 CID_123074 | ||
| 0.113 | 0.056 | 0.113 | MAP kinase kinase kinase inhibitor | |||
| 0.076 | 0.02 | 0.076 | Sphingosine 1-phosphate receptor 3 antagonist | 0.054 0.048 CID_123074 | ||
| 0.062 | 0.005 | 0.062 | Angiotensin AT1 receptor antagonist | 0.042 0.029 CID_439929 0.046 0.023 CID_9543118 0.051 0.016 CID_123074 | ||
| 0.066 | 0.01 | 0.069 | Liver X receptor alpha agonist | 0.058 0.014 CID_439929 0.069 0.009 CID_9543118 0.058 0.014 CID_123074 | CID_9543118 | |
| 0.068 | 0.011 | 0.077 | Urate transporter 1 inhibitor | 0.045 0.022 CID_439929 0.059 0.014 CID_9543118 0.077 0.009 CID_123074 | CID_123074 | |
| 0.081 | 0.025 | 0.081 | TRPA1 antagonist | 0.06 0.043 CID_123074 | ||
| 0.076 | 0.02 | 0.078 | Botulinum neurotoxin type A inhibitor | 0.078 0.019 CID_439929 0.068 0.027 CID_9543118 0.073 0.022 CID_123074 | CID_439929 | |
| 0.068 | 0.012 | 0.068 | Mannosidase inhibitor | 0.05 0.025 CID_439929 0.05 0.025 CID_9543118 0.066 0.014 CID_123074 | ||
| 0.068 | 0.012 | 0.068 | Potassium channel (Inward rectifier) activator | 0.054 0.028 CID_123074 | ||
| 0.06 | 0.005 | 0.06 | Vanilloid 3 antagonist | 0.045 0.013 CID_439929 0.048 0.01 CID_9543118 0.05 0.008 CID_123074 | ||
| 0.092 | 0.036 | 0.092 | NMDA 2 receptor antagonist | 0.063 0.059 CID_439929 0.072 0.049 CID_9543118 0.075 0.047 CID_123074 | ||
| 0.102 | 0.046 | 0.102 | Potassium channel activator | 0.094 0.055 CID_123074 | ||
| 0.065 | 0.01 | 0.065 | Glutamate (mGluR group II) antagonist | 0.034 0.032 CID_123074 | ||
| 0.121 | 0.066 | 0.121 | Acetylcholine muscarinic antagonist | 0.101 0.09 CID_439929 0.104 0.086 CID_123074 | ||
| 0.08 | 0.025 | 0.161 | Xanthine dehydrogenase inhibitor | 0.15 0.007 CID_439929 0.161 0.006 CID_9543118 0.127 0.01 CID_123074 | CID_9543118 | |
| 0.078 | 0.023 | 0.094 | Transcription factor AP-1 inhibitor | 0.094 0.015 CID_439929 0.076 0.024 CID_9543118 0.065 0.037 CID_123074 | CID_439929 | |
| 0.106 | 0.052 | 0.243 | Protein kinase C mu inhibitor | 0.243 0.008 CID_439929 0.156 0.023 CID_9543118 0.151 0.025 CID_123074 | CID_439929 | |
| 0.091 | 0.036 | 0.091 | Acetylcholine M4 receptor antagonist | |||
| 0.064 | 0.01 | 0.229 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.229 0.003 CID_439929 0.152 0.004 CID_9543118 0.144 0.004 CID_123074 | CID_439929 | |
| 0.095 | 0.04 | 0.095 | Histamine H2 receptor antagonist | |||
| 0.066 | 0.013 | 0.066 | Cholesterol esterase inhibitor | 0.056 0.021 CID_439929 0.063 0.015 CID_9543118 0.063 0.015 CID_123074 | ||
| 0.117 | 0.064 | 0.14 | Protein kinase (CK2) alpha inhibitor | 0.14 0.048 CID_439929 0.14 0.048 CID_9543118 0.135 0.052 CID_123074 | CID_9543118 | |
| 0.061 | 0.008 | 0.061 | 5 Hydroxytryptamine 2B agonist | 0.036 0.034 CID_123074 | ||
| 0.069 | 0.016 | 0.193 | Estradiol 17 beta-dehydrogenase inhibitor | 0.193 0.005 CID_439929 0.18 0.005 CID_9543118 0.138 0.007 CID_123074 | CID_439929 | |
| 0.059 | 0.006 | 0.059 | Heme oxygenase inhibitor | 0.045 0.023 CID_439929 0.045 0.023 CID_9543118 0.046 0.02 CID_123074 | ||
| 0.065 | 0.012 | 0.065 | Potassium channel (ATP-sensitive) activator | 0.051 0.027 CID_123074 | ||
| 0.086 | 0.033 | 0.086 | Phosphodiesterase VI inhibitor | |||
| 0.072 | 0.02 | 0.072 | AMPA receptor antagonist | 0.045 0.036 CID_123074 | ||
| 0.078 | 0.026 | 0.078 | Dopamine uptake inhibitor | |||
| 0.074 | 0.022 | 0.539 | Alpha tubulin antagonist | 0.539 0.004 CID_439929 0.251 0.005 CID_9543118 0.207 0.006 CID_123074 | CID_439929 | |
| 0.099 | 0.047 | 0.099 | Acetylcholine agonist | |||
| 0.079 | 0.028 | 0.079 | Cannabinoid CB1 receptor antagonist | |||
| 0.065 | 0.013 | 0.065 | Progesterone antagonist | 0.031 0.028 CID_439929 0.045 0.02 CID_9543118 0.049 0.019 CID_123074 | ||
| 0.06 | 0.009 | 0.06 | Potassium channel small-conductance Ca-activated activator | |||
| 0.107 | 0.056 | 0.127 | MAO B inhibitor | 0.081 0.074 CID_439929 0.127 0.047 CID_9543118 0.114 0.053 CID_123074 | CID_9543118 | |
| 0.094 | 0.044 | 0.094 | I kappa B kinase inhibitor | 0.073 0.071 CID_123074 | ||
| 0.059 | 0.008 | 0.059 | Phenylethanolamine N methyltransferase inhibitor | 0.04 0.03 CID_123074 | ||
| 0.076 | 0.026 | 0.104 | Beta 3 adrenoreceptor antagonist | 0.1 0.015 CID_439929 0.104 0.014 CID_9543118 0.092 0.017 CID_123074 | CID_9543118 | |
| 0.113 | 0.063 | 0.113 | Polo-like kinase-4 inhibitor | |||
| 0.056 | 0.006 | 0.056 | Liver X receptor beta antagonist | 0.041 0.012 CID_439929 0.049 0.009 CID_9543118 0.048 0.009 CID_123074 | ||
| 0.055 | 0.005 | 0.055 | Angiotensin II receptor antagonist | 0.031 0.029 CID_439929 0.035 0.022 CID_9543118 0.039 0.016 CID_123074 | ||
| 0.076 | 0.026 | 0.076 | I kappa B kinase 2 inhibitor | 0.059 0.05 CID_9543118 0.063 0.042 CID_123074 | ||
| 0.074 | 0.025 | 0.074 | Nicotinic neuronal receptor agonist | |||
| 0.058 | 0.009 | 0.058 | Angiotensin AT2 receptor antagonist | |||
| 0.093 | 0.044 | 0.093 | Acetylcholine nicotinic antagonist | |||
| 0.084 | 0.035 | 0.084 | Calcium channel L-type blocker | |||
| 0.097 | 0.048 | 0.097 | Pim-3 kinase inhibitor | |||
| 0.056 | 0.008 | 0.056 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.029 0.018 CID_439929 0.029 0.018 CID_9543118 0.038 0.013 CID_123074 | ||
| 0.065 | 0.017 | 0.078 | NMDA receptor subunit 3B antagonist | 0.05 0.025 CID_439929 0.056 0.021 CID_9543118 0.078 0.014 CID_123074 | CID_123074 | |
| 0.079 | 0.032 | 0.079 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.054 | 0.006 | 0.054 | Methionyl aminopeptidase 2 inhibitor | 0.023 0.021 CID_9543118 0.035 0.011 CID_123074 | ||
| 0.07 | 0.023 | 0.07 | Protein kinase C theta inhibitor | |||
| 0.081 | 0.034 | 0.081 | Transforming growth factor antagonist | |||
| 0.063 | 0.016 | 0.063 | Glutamate (mGluR5) agonist | |||
| 0.066 | 0.019 | 0.066 | Glutamate (mGluR group I) agonist | |||
| 0.082 | 0.035 | 0.082 | Neuronal nicotinic receptor antagonist | |||
| 0.096 | 0.05 | 0.186 | Antineoplastic alkaloid | 0.186 0.018 CID_439929 0.108 0.043 CID_9543118 0.114 0.04 CID_123074 | CID_439929 | |
| 0.079 | 0.033 | 0.229 | Dopamine D1 antagonist | 0.229 0.009 CID_439929 0.183 0.012 CID_9543118 0.159 0.014 CID_123074 | CID_439929 | |
| 0.054 | 0.008 | 0.054 | Free fatty acid receptor 1 antagonist | 0.035 0.022 CID_439929 0.04 0.016 CID_9543118 0.041 0.015 CID_123074 | ||
| 0.065 | 0.019 | 0.065 | Prolyl endopeptidase inhibitor | 0.052 0.034 CID_439929 0.049 0.037 CID_9543118 0.053 0.032 CID_123074 | ||
| 0.052 | 0.007 | 0.052 | NMDA 2D receptor antagonist | |||
| 0.049 | 0.004 | 0.049 | Microsomal triglyceride transfer protein inhibitor | |||
| 0.071 | 0.026 | 0.071 | Histone deacetylase SIRT3 inhibitor | 0.059 0.054 CID_123074 | ||
| 0.054 | 0.009 | 0.056 | Retinoid X receptor antagonist | 0.04 0.023 CID_439929 0.048 0.014 CID_9543118 0.056 0.008 CID_123074 | CID_123074 | |
| 0.063 | 0.019 | 0.063 | Oleamide hydrolase inhibitor | |||
| 0.095 | 0.05 | 0.095 | NMDA receptor antagonist | 0.085 0.059 CID_439929 0.076 0.07 CID_9543118 0.086 0.059 CID_123074 | ||
| 0.049 | 0.005 | 0.049 | Tryptophan 5 hydroxylase inhibitor | 0.043 0.011 CID_439929 0.038 0.018 CID_9543118 0.039 0.016 CID_123074 | ||
| 0.076 | 0.032 | 0.076 | Potassium channel (ATP-sensitive) blocker | 0.062 0.057 CID_123074 | ||
| 0.067 | 0.023 | 0.084 | Dihydroorotate dehydrogenase inhibitor | 0.059 0.029 CID_439929 0.084 0.016 CID_9543118 0.077 0.019 CID_123074 | CID_9543118 | |
| 0.049 | 0.005 | 0.049 | Nicotinic alpha3beta4 receptor agonist | 0.033 0.016 CID_123074 | ||
| 0.054 | 0.011 | 0.054 | Potassium channel Kv1.1 blocker | 0.035 0.033 CID_123074 | ||
| 0.067 | 0.023 | 0.067 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.053 | 0.01 | 0.053 | Delayed rectifier potassium channel blocker | 0.039 0.023 CID_9543118 0.045 0.016 CID_123074 | ||
| 0.051 | 0.008 | 0.051 | Uridine phosphorylase inhibitor | 0.033 0.015 CID_439929 0.033 0.015 CID_9543118 0.046 0.009 CID_123074 | ||
| 0.06 | 0.017 | 0.068 | NMDA receptor subunit 3A antagonist | 0.039 0.026 CID_439929 0.044 0.023 CID_9543118 0.068 0.015 CID_123074 | CID_123074 | |
| 0.103 | 0.061 | 0.124 | Protein kinase (CK2) inhibitor | 0.119 0.049 CID_439929 0.123 0.046 CID_9543118 0.124 0.045 CID_123074 | CID_123074 | |
| 0.071 | 0.029 | 0.071 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.079 | 0.036 | 0.079 | Sirtuin 1 inhibitor | |||
| 0.058 | 0.016 | 0.058 | AICAR transformylase inhibitor | 0.04 0.038 CID_439929 0.045 0.029 CID_9543118 0.052 0.02 CID_123074 | ||
| 0.05 | 0.008 | 0.068 | ATP citrate lysase inhibitor | 0.053 0.007 CID_439929 0.067 0.005 CID_9543118 0.068 0.004 CID_123074 | CID_123074 | |
| 0.085 | 0.043 | 0.085 | Rho-associated kinase inhibitor | |||
| 0.054 | 0.013 | 0.054 | AMPA 4 receptor antagonist | 0.044 0.021 CID_123074 | ||
| 0.055 | 0.014 | 0.055 | TRPM8 blocker | |||
| 0.069 | 0.028 | 0.069 | Alpha 1 adrenoreceptor agonist | 0.059 0.038 CID_439929 0.056 0.042 CID_9543118 0.055 0.042 CID_123074 | ||
| 0.048 | 0.008 | 0.048 | Ceramide glucosyltransferase inhibitor | 0.038 0.02 CID_439929 0.04 0.016 CID_9543118 0.042 0.014 CID_123074 | ||
| 0.06 | 0.02 | 0.06 | Farnesyltransferase inhibitor | |||
| 0.049 | 0.009 | 0.049 | Glutamate (mGluR2) antagonist | |||
| 0.104 | 0.065 | 0.164 | Mediator release inhibitor | 0.123 0.044 CID_439929 0.152 0.028 CID_9543118 0.164 0.023 CID_123074 | CID_123074 | |
| 0.05 | 0.011 | 0.05 | Glutamate (mGluR4) agonist | 0.037 0.019 CID_123074 | ||
| 0.074 | 0.035 | 0.074 | Orexin receptor antagonist | |||
| 0.057 | 0.018 | 0.057 | CC chemokine 4 receptor antagonist | |||
| 0.079 | 0.04 | 0.079 | Cannabinoid receptor antagonist | |||
| 0.091 | 0.052 | 0.091 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.06 | 0.021 | 0.06 | Adenosine deaminase inhibitor | 0.042 0.038 CID_439929 0.042 0.038 CID_9543118 0.053 0.027 CID_123074 | ||
| 0.048 | 0.01 | 0.052 | CF transmembrane conductance regulator antagonist | 0.048 0.01 CID_439929 0.049 0.009 CID_9543118 0.052 0.007 CID_123074 | CID_123074 | |
| 0.048 | 0.01 | 0.048 | Liver X receptor antagonist | 0.031 0.022 CID_439929 0.039 0.014 CID_9543118 0.033 0.019 CID_123074 | ||
| 0.081 | 0.042 | 0.081 | Adenosine A3 receptor antagonist | |||
| 0.082 | 0.044 | 0.082 | Rho-associated kinase I inhibitor | |||
| 0.047 | 0.008 | 0.047 | Retinoid X alpha receptor antagonist | 0.034 0.024 CID_439929 0.04 0.015 CID_9543118 0.047 0.008 CID_123074 | ||
| 0.059 | 0.021 | 0.059 | 5 Hydroxytryptamine 2C agonist | |||
| 0.062 | 0.024 | 0.063 | Leukotriene C antagonist | 0.059 0.032 CID_439929 0.06 0.029 CID_9543118 0.063 0.024 CID_123074 | CID_123074 | |
| 0.042 | 0.005 | 0.042 | Nicotinic acid receptor 2 antagonist | 0.026 0.02 CID_439929 0.026 0.02 CID_9543118 0.033 0.009 CID_123074 | ||
| 0.094 | 0.056 | 0.104 | Thioredoxin inhibitor | 0.1 0.048 CID_9543118 0.104 0.044 CID_123074 | CID_123074 | |
| 0.041 | 0.004 | 0.041 | Complement factor 1s inhibitor | 0.025 0.018 CID_439929 0.027 0.013 CID_9543118 0.029 0.009 CID_123074 | ||
| 0.077 | 0.039 | 0.077 | Peroxisome proliferator-activated receptor gamma antagonist | 0.069 0.056 CID_439929 0.069 0.056 CID_9543118 0.07 0.054 CID_123074 | ||
| 0.048 | 0.011 | 0.048 | Liver X receptor beta agonist | 0.03 0.028 CID_439929 0.034 0.022 CID_9543118 0.032 0.024 CID_123074 | ||
| 0.069 | 0.032 | 0.069 | Acetylcholine M5 receptor antagonist | |||
| 0.05 | 0.013 | 0.05 | MAP3K5 inhibitor | 0.037 0.031 CID_123074 | ||
| 0.055 | 0.018 | 0.055 | Glutamate (mGluR1a) antagonist | |||
| 0.054 | 0.016 | 0.054 | Thymidine kinase inhibitor | 0.048 0.02 CID_123074 | ||
| 0.043 | 0.005 | 0.043 | Purinergic P2Y15 antagonist | 0.032 0.014 CID_439929 0.032 0.014 CID_9543118 0.036 0.009 CID_123074 | ||
| 0.049 | 0.012 | 0.049 | Integrin alpha2 antagonist | 0.035 0.03 CID_123074 | ||
| 0.044 | 0.007 | 0.044 | Liver X receptor alpha antagonist | 0.033 0.015 CID_439929 0.04 0.009 CID_9543118 0.034 0.013 CID_123074 | ||
| 0.041 | 0.004 | 0.041 | Hedgehog signaling activator | 0.033 0.008 CID_439929 0.038 0.005 CID_9543118 0.038 0.005 CID_123074 | ||
| 0.076 | 0.039 | 0.076 | CDC7 inhibitor | |||
| 0.086 | 0.05 | 0.127 | Adrenaline agonist | 0.121 0.025 CID_439929 0.127 0.022 CID_9543118 0.115 0.028 CID_123074 | CID_9543118 | |
| 0.051 | 0.014 | 0.051 | Nicotinic acid receptor agonist | 0.034 0.028 CID_439929 0.037 0.024 CID_9543118 0.047 0.016 CID_123074 | ||
| 0.115 | 0.079 | 0.115 | Cholinergic antagonist | |||
| 0.057 | 0.021 | 0.057 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.054 | 0.019 | 0.054 | Kainate receptor antagonist | 0.039 0.03 CID_123074 | ||
| 0.05 | 0.014 | 0.05 | Phosphoglycerate kinase inhibitor | 0.041 0.019 CID_439929 0.041 0.019 CID_9543118 0.046 0.015 CID_123074 | ||
| 0.05 | 0.014 | 0.05 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.043 | 0.008 | 0.116 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.116 0.004 CID_439929 0.106 0.004 CID_9543118 0.077 0.005 CID_123074 | CID_439929 | |
| 0.051 | 0.016 | 0.051 | Kainate receptor 2 antagonist | 0.036 0.025 CID_123074 | ||
| 0.107 | 0.072 | 0.24 | Protein-tyrosine phosphatase 1B inhibitor | 0.24 0.019 CID_439929 0.23 0.021 CID_9543118 0.2 0.029 CID_123074 | CID_439929 | |
| 0.045 | 0.01 | 0.045 | Lysophosphatidic acid 2 receptor antagonist | 0.029 0.023 CID_439929 0.033 0.018 CID_9543118 0.035 0.016 CID_123074 | ||
| 0.051 | 0.017 | 0.051 | Dihydrofolate reductase inhibitor | |||
| 0.088 | 0.054 | 0.127 | Protein kinase A inhibitor | 0.127 0.031 CID_439929 0.088 0.054 CID_9543118 | CID_439929 | |
| 0.08 | 0.046 | 0.08 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.137 | 0.104 | 0.464 | Mcl-1 antagonist | 0.378 0.013 CID_439929 0.464 0.007 CID_9543118 0.422 0.009 CID_123074 | CID_9543118 | |
| 0.036 | 0.003 | 0.036 | Imidazoline I2 receptor antagonist | 0.01 0.009 CID_439929 0.012 0.006 CID_9543118 0.013 0.005 CID_123074 | ||
| 0.039 | 0.005 | 0.044 | Estrogen-related receptor gamma antagonist | 0.039 0.005 CID_439929 0.039 0.005 CID_9543118 0.044 0.004 CID_123074 | CID_123074 | |
| 0.05 | 0.017 | 0.05 | Sphingosine kinase 1 inhibitor | 0.043 0.026 CID_439929 0.046 0.021 CID_9543118 0.046 0.021 CID_123074 | ||
| 0.067 | 0.034 | 0.067 | Carbonic anhydrase IX inhibitor | |||
| 0.103 | 0.07 | 0.103 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.061 | 0.029 | 0.061 | Cannabinoid CB2 receptor antagonist | |||
| 0.058 | 0.026 | 0.058 | Glycine transporter 2 inhibitor | |||
| 0.037 | 0.005 | 0.037 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.059 | 0.027 | 0.059 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.037 | 0.005 | 0.037 | Acid ceramidase inhibitor | |||
| 0.04 | 0.008 | 0.04 | 5 Hydroxytryptamine 6 agonist | |||
| 0.038 | 0.006 | 0.038 | Lysophosphatidic acid receptor 1 agonist | 0.026 0.016 CID_123074 | ||
| 0.055 | 0.023 | 0.055 | Purinergic P2Y antagonist | 0.051 0.026 CID_123074 | ||
| 0.078 | 0.047 | 0.078 | Rho-associated kinase II inhibitor | |||
| 0.036 | 0.004 | 0.036 | Alpha 2c adrenoreceptor agonist | 0.021 0.01 CID_9543118 0.02 0.011 CID_123074 | ||
| 0.049 | 0.017 | 0.049 | Dihydropteroate synthase inhibitor | 0.036 0.033 CID_439929 0.036 0.033 CID_9543118 0.045 0.021 CID_123074 | ||
| 0.059 | 0.028 | 0.059 | 5 Hydroxytryptamine 1B agonist | |||
| 0.111 | 0.079 | 0.111 | Acetylcholine antagonist | |||
| 0.066 | 0.035 | 0.066 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.055 | 0.024 | 0.055 | Histamine H4 receptor antagonist | |||
| 0.039 | 0.008 | 0.039 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.049 | 0.018 | 0.049 | Histone deacetylase 7 inhibitor | |||
| 0.042 | 0.011 | 0.042 | Transforming growth factor beta 2 antagonist | |||
| 0.057 | 0.027 | 0.057 | Carbonic anhydrase XIV inhibitor | 0.056 0.028 CID_439929 0.056 0.028 CID_9543118 0.048 0.035 CID_123074 | ||
| 0.056 | 0.025 | 0.056 | HCV NS3/NS4A protease inhibitor | 0.045 0.043 CID_439929 0.047 0.038 CID_123074 | ||
| 0.048 | 0.017 | 0.048 | Vascular adhesion protein 1 inhibitor | |||
| 0.07 | 0.039 | 0.103 | Beta adrenoreceptor antagonist | 0.095 0.018 CID_439929 0.103 0.015 CID_9543118 0.094 0.019 CID_123074 | CID_9543118 | |
| 0.098 | 0.067 | 0.098 | Check point kinase 2 inhibitor | |||
| 0.063 | 0.033 | 0.085 | Beta 1 adrenoreceptor antagonist | 0.08 0.018 CID_439929 0.085 0.015 CID_9543118 0.08 0.018 CID_123074 | CID_9543118 | |
| 0.035 | 0.005 | 0.037 | Vanilloid 2 agonist | 0.03 0.01 CID_439929 0.03 0.01 CID_9543118 0.037 0.005 CID_123074 | CID_123074 | |
| 0.065 | 0.035 | 0.065 | Glutamate (mGluR1) antagonist | |||
| 0.042 | 0.012 | 0.042 | Cholesterol ester transfer protein antagonist | 0.029 0.025 CID_439929 0.042 0.012 CID_9543118 0.042 0.011 CID_123074 | ||
| 0.052 | 0.022 | 0.054 | Oxytocin agonist | 0.044 0.028 CID_439929 0.044 0.028 CID_9543118 0.054 0.021 CID_123074 | CID_123074 | |
| 0.047 | 0.018 | 0.047 | Histone deacetylase 9 inhibitor | |||
| 0.06 | 0.031 | 0.06 | Toll-Like receptor 8 antagonist | |||
| 0.047 | 0.018 | 0.047 | Membrane dipeptidase inhibitor | 0.041 0.025 CID_123074 | ||
| 0.064 | 0.035 | 0.073 | Beta 2 adrenoreceptor agonist | 0.07 0.018 CID_439929 0.073 0.015 CID_9543118 0.07 0.019 CID_123074 | CID_9543118 | |
| 0.042 | 0.013 | 0.042 | Melatonin 1 agonist | |||
| 0.041 | 0.012 | 0.041 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.108 | 0.079 | 0.108 | TRKA antagonist | |||
| 0.035 | 0.007 | 0.035 | Glutamate (mGluR1) agonist | 0.029 0.011 CID_123074 | ||
| 0.036 | 0.008 | 0.036 | Integrin alpha2beta1 antagonist | 0.025 0.021 CID_123074 | ||
| 0.09 | 0.062 | 0.09 | Polo-like kinase-1 inhibitor | |||
| 0.036 | 0.008 | 0.036 | Thymidine phosphorylase inhibitor | 0.029 0.013 CID_439929 0.029 0.013 CID_9543118 0.031 0.011 CID_123074 | ||
| 0.04 | 0.012 | 0.051 | Protein kinase (CK2) beta inhibitor | 0.039 0.013 CID_439929 0.043 0.01 CID_9543118 0.051 0.007 CID_123074 | CID_123074 | |
| 0.052 | 0.024 | 0.052 | Carbonic anhydrase IV inhibitor | |||
| 0.033 | 0.005 | 0.033 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.022 0.02 CID_439929 0.022 0.02 CID_9543118 0.024 0.016 CID_123074 | ||
| 0.048 | 0.02 | 0.048 | Plasmepsin II inhibitor | |||
| 0.059 | 0.031 | 0.059 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.039 | 0.012 | 0.039 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.068 | 0.041 | 0.068 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.038 | 0.012 | 0.041 | Glutamate (mGluR3) agonist | 0.035 0.016 CID_439929 0.035 0.016 CID_9543118 0.041 0.009 CID_123074 | CID_123074 | |
| 0.057 | 0.031 | 0.072 | Leukotriene B4 antagonist | 0.06 0.028 CID_439929 0.072 0.019 CID_9543118 0.064 0.024 CID_123074 | CID_9543118 | |
| 0.034 | 0.008 | 0.034 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.023 CID_439929 0.025 0.023 CID_9543118 0.029 0.012 CID_123074 | ||
| 0.034 | 0.008 | 0.034 | Geranylgeranyltransferase inhibitor | |||
| 0.034 | 0.008 | 0.034 | Glucosylceramidase stimulant | |||
| 0.041 | 0.015 | 0.063 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.048 0.012 CID_439929 0.063 0.008 CID_9543118 0.059 0.008 CID_123074 | CID_9543118 | |
| 0.078 | 0.052 | 0.078 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.058 | 0.032 | 0.059 | Protein kinase C epsilon inhibitor | 0.059 0.032 CID_439929 | CID_439929 | |
| 0.061 | 0.035 | 0.061 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.038 | 0.012 | 0.038 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.07 | 0.044 | 0.649 | Dopamine agonist | 0.649 0.004 CID_439929 0.484 0.004 CID_9543118 0.4 0.005 CID_123074 | CID_439929 | |
| 0.039 | 0.014 | 0.039 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.254 | 0.229 | 0.254 | MAP kinase 1 inhibitor | |||
| 0.055 | 0.03 | 0.055 | Transforming growth factor beta 1 antagonist | |||
| 0.053 | 0.028 | 0.053 | Alpha 1b adrenoreceptor agonist | |||
| 0.029 | 0.005 | 0.029 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.017 CID_439929 0.02 0.017 CID_9543118 0.024 0.008 CID_123074 | ||
| 0.049 | 0.024 | 0.049 | Liver X receptor agonist | |||
| 0.034 | 0.009 | 0.034 | Myristoyl transferase inhibitor | |||
| 0.054 | 0.029 | 0.054 | Dopamine transporter inhibitor | |||
| 0.038 | 0.013 | 0.038 | Epoxide hydrolase 1 inhibitor | |||
| 0.067 | 0.043 | 0.067 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.057 | 0.033 | 0.057 | Thromboxane synthase inhibitor | 0.05 0.049 CID_123074 | ||
| 0.034 | 0.01 | 0.034 | Calcium-sensing receptor agonist | |||
| 0.028 | 0.005 | 0.029 | Nicotinic acid receptor 1 antagonist | 0.025 0.005 CID_439929 0.025 0.005 CID_9543118 0.029 0.004 CID_123074 | CID_123074 | |
| 0.063 | 0.039 | 0.068 | Heme oxygenase stimulant | 0.065 0.033 CID_439929 0.065 0.033 CID_9543118 0.068 0.028 CID_123074 | CID_123074 | |
| 0.043 | 0.02 | 0.043 | Arginase inhibitor | 0.033 0.029 CID_439929 0.033 0.029 CID_9543118 0.036 0.026 CID_123074 | ||
| 0.03 | 0.006 | 0.03 | Angiotensin AT1A receptor antagonist | |||
| 0.058 | 0.035 | 0.058 | Acetylcholine muscarinic agonist | |||
| 0.039 | 0.016 | 0.039 | Melatonin agonist | |||
| 0.056 | 0.032 | 0.056 | Histamine agonist | |||
| 0.054 | 0.031 | 0.079 | Beta 2 adrenoreceptor antagonist | 0.076 0.013 CID_439929 0.079 0.012 CID_9543118 0.073 0.015 CID_123074 | CID_9543118 | |
| 0.054 | 0.031 | 0.054 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.116 | 0.092 | 0.116 | Calcium channel blocker | |||
| 0.049 | 0.026 | 0.049 | Sphingosine 1-phosphate receptor agonist | |||
| 0.043 | 0.02 | 0.043 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.225 | 0.202 | 0.427 | Alpha-glucosidase inhibitor | 0.427 0.104 CID_439929 0.41 0.11 CID_9543118 0.361 0.131 CID_123074 | CID_439929 | |
| 0.027 | 0.005 | 0.027 | Alpha 2b adrenoreceptor agonist | 0.02 0.011 CID_9543118 0.02 0.01 CID_123074 | ||
| 0.034 | 0.011 | 0.034 | MAP3K8 inhibitor | |||
| 0.063 | 0.04 | 0.063 | Cannabinoid CB1 receptor agonist | |||
| 0.054 | 0.031 | 0.054 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.226 | 0.204 | 0.231 | Transcription factor inhibitor | 0.215 0.214 CID_9543118 0.231 0.201 CID_123074 | CID_123074 | |
| 0.113 | 0.091 | 0.113 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.027 | 0.005 | 0.027 | Retinoid X beta receptor antagonist | 0.021 0.013 CID_9543118 0.026 0.006 CID_123074 | ||
| 0.068 | 0.047 | 0.068 | Check point kinase 1 inhibitor | |||
| 0.043 | 0.022 | 0.043 | 5-Alpha-reductase inhibitor | 0.032 0.031 CID_123074 | ||
| 0.056 | 0.035 | 0.056 | GABA receptor antagonist | 0.05 0.044 CID_123074 | ||
| 0.031 | 0.01 | 0.031 | Adenosine kinase inhibitor | |||
| 0.045 | 0.025 | 0.045 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.034 | 0.013 | 0.034 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.064 | 0.043 | 0.064 | Carbonic anhydrase inhibitor | |||
| 0.06 | 0.039 | 0.06 | Cyclin A1 inhibitor | |||
| 0.032 | 0.012 | 0.036 | Sodium/glucose cotransporter 2 inhibitor | 0.027 0.016 CID_439929 0.029 0.014 CID_9543118 0.036 0.01 CID_123074 | CID_123074 | |
| 0.062 | 0.042 | 0.062 | Adrenaline uptake inhibitor | |||
| 0.068 | 0.048 | 0.068 | MAP kinase kinase 8 inhibitor | |||
| 0.024 | 0.004 | 0.024 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.018 0.005 CID_439929 0.018 0.005 CID_9543118 0.017 0.005 CID_123074 | ||
| 0.033 | 0.013 | 0.033 | LFA antagonist | |||
| 0.037 | 0.017 | 0.037 | Dipeptidyl peptidase II inhibitor | |||
| 0.036 | 0.016 | 0.036 | Protein kinase C beta I inhibitor | |||
| 0.025 | 0.005 | 0.031 | Antibiotic Anthracycline-like | 0.024 0.006 CID_439929 0.028 0.004 CID_9543118 0.031 0.004 CID_123074 | CID_123074 | |
| 0.081 | 0.061 | 0.081 | Phosphodiesterase IV inhibitor | |||
| 0.055 | 0.035 | 0.055 | GABA A receptor antagonist | |||
| 0.025 | 0.005 | 0.025 | Carbonic anhydrase VIII inhibitor | 0.015 0.014 CID_123074 | ||
| 0.025 | 0.005 | 0.025 | Carbonic anhydrase X inhibitor | 0.015 0.014 CID_123074 | ||
| 0.208 | 0.189 | 0.387 | Immunosuppressant | 0.366 0.079 CID_439929 0.361 0.081 CID_9543118 0.387 0.069 CID_123074 | CID_123074 | |
| 0.037 | 0.018 | 0.037 | Adenosine uptake inhibitor | |||
| 0.06 | 0.041 | 0.06 | Acetylcholine M3 receptor antagonist | |||
| 0.055 | 0.035 | 0.055 | Carbonic anhydrase XII inhibitor | |||
| 0.065 | 0.045 | 0.065 | Neutrophil collagenase inhibitor | 0.059 0.052 CID_439929 0.062 0.048 CID_9543118 0.057 0.054 CID_123074 | ||
| 0.024 | 0.005 | 0.024 | NMDA receptor phencyclidine site antagonist | 0.014 0.013 CID_439929 0.015 0.011 CID_9543118 0.021 0.007 CID_123074 | ||
| 0.027 | 0.008 | 0.027 | Isoleucine-tRNA ligase inhibitor | 0.023 0.014 CID_439929 0.023 0.014 CID_9543118 0.024 0.012 CID_123074 | ||
| 0.022 | 0.003 | 0.022 | Progesterone receptor A antagonist | 0.011 0.005 CID_439929 0.011 0.005 CID_9543118 0.015 0.004 CID_123074 | ||
| 0.041 | 0.023 | 0.041 | Farnesoid X receptor agonist | |||
| 0.022 | 0.005 | 0.022 | Lysophosphatidic acid receptor 3 agonist | 0.013 0.01 CID_123074 | ||
| 0.041 | 0.023 | 0.041 | Leukotriene C4 antagonist | 0.037 0.033 CID_439929 0.037 0.033 CID_9543118 0.04 0.025 CID_123074 | ||
| 0.053 | 0.036 | 0.053 | Dipeptidyl peptidase inhibitor | |||
| 0.036 | 0.019 | 0.036 | Calcium release-activated channel blocker | |||
| 0.034 | 0.017 | 0.034 | 5 Hydroxytryptamine 1D agonist | |||
| 0.077 | 0.06 | 0.077 | Histamine H1 receptor antagonist | |||
| 0.023 | 0.006 | 0.023 | Complement factor D inhibitor | |||
| 0.073 | 0.056 | 0.073 | Glutamate (mGluR) antagonist | |||
| 0.029 | 0.012 | 0.029 | Complement factor 1r inhibitor | |||
| 0.027 | 0.01 | 0.027 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.024 0.011 CID_9543118 0.021 0.013 CID_123074 | ||
| 0.091 | 0.074 | 0.091 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.071 | 0.054 | 0.071 | Metalloproteinase-9 inhibitor | 0.068 0.059 CID_439929 0.07 0.055 CID_9543118 | ||
| 0.188 | 0.172 | 0.211 | Thyroid hormone antagonist | 0.191 0.17 CID_439929 0.2 0.162 CID_9543118 0.211 0.153 CID_123074 | CID_123074 | |
| 0.05 | 0.033 | 0.05 | Bombesin 2 receptor antagonist | |||
| 0.039 | 0.022 | 0.039 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.063 | 0.047 | 0.072 | Leukotriene antagonist | 0.059 0.052 CID_439929 0.072 0.038 CID_9543118 0.07 0.04 CID_123074 | CID_9543118 | |
| 0.064 | 0.048 | 0.064 | Histone deacetylase inhibitor | |||
| 0.021 | 0.005 | 0.021 | Thromboxane A2 agonist | 0.018 0.007 CID_123074 | ||
| 0.077 | 0.061 | 0.077 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.036 | 0.02 | 0.036 | Purinergic P2Y2 antagonist | 0.031 0.028 CID_9543118 0.033 0.024 CID_123074 | ||
| 0.025 | 0.01 | 0.025 | Apolipoprotein B inhibitor | |||
| 0.029 | 0.013 | 0.03 | Sodium/glucose cotransporter inhibitor | 0.025 0.019 CID_439929 0.026 0.016 CID_9543118 0.03 0.011 CID_123074 | CID_123074 | |
| 0.034 | 0.018 | 0.034 | Acetylcholine M4 receptor agonist | |||
| 0.048 | 0.033 | 0.048 | Mineralocorticoid receptor antagonist | |||
| 0.022 | 0.006 | 0.023 | Telomerase stimulant | 0.019 0.009 CID_439929 0.019 0.009 CID_9543118 0.023 0.005 CID_123074 | CID_123074 | |
| 0.1 | 0.084 | 0.1 | Calcium channel (voltage-sensitive) blocker | |||
| 0.055 | 0.04 | 0.055 | Phosphodiesterase 4C inhibitor | |||
| 0.149 | 0.134 | 0.149 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.044 | 0.029 | 0.044 | Acetylcholine M1 receptor agonist | |||
| 0.08 | 0.065 | 0.08 | Bcr-Abl kinase inhibitor | |||
| 0.026 | 0.011 | 0.026 | Prostaglandin F2 alpha agonist | 0.023 0.015 CID_439929 0.023 0.015 CID_9543118 0.026 0.011 CID_123074 | ||
| 0.074 | 0.059 | 0.074 | Metalloproteinase-2 inhibitor | 0.07 0.065 CID_9543118 | ||
| 0.044 | 0.029 | 0.395 | Dopamine D5 antagonist | 0.395 0.003 CID_439929 0.223 0.005 CID_9543118 0.208 0.005 CID_123074 | CID_439929 | |
| 0.02 | 0.006 | 0.02 | Angiotensin AT1B receptor antagonist | |||
| 0.023 | 0.008 | 0.023 | Cyclin T1 inhibitor | |||
| 0.029 | 0.014 | 0.029 | Prostaglandin H2 antagonist | 0.023 0.02 CID_123074 | ||
| 0.033 | 0.018 | 0.033 | Peptide deformylase inhibitor | |||
| 0.038 | 0.023 | 0.038 | Orexin receptor 2 antagonist | |||
| 0.025 | 0.011 | 0.025 | ICAM 1 antagonist | |||
| 0.042 | 0.028 | 0.042 | CDK5/p25 inhibitor | |||
| 0.042 | 0.028 | 0.043 | Histone deacetylase 8 inhibitor | 0.036 0.033 CID_439929 0.043 0.027 CID_9543118 0.042 0.028 CID_123074 | CID_9543118 | |
| 0.043 | 0.03 | 0.043 | Leukocyte elastase inhibitor | |||
| 0.039 | 0.025 | 0.039 | DNA gyrase subunit B inhibitor | |||
| 0.134 | 0.121 | 0.561 | Amyloid beta aggregation inhibitor | 0.515 0.013 CID_439929 0.561 0.01 CID_9543118 0.439 0.02 CID_123074 | CID_9543118 | |
| 0.023 | 0.01 | 0.023 | Neuraminidase (Influenza B) inhibitor | 0.021 0.015 CID_123074 | ||
| 0.038 | 0.024 | 0.038 | Potassium channel KCNQ activator | |||
| 0.038 | 0.024 | 0.038 | Delayed rectifier potassium channel activator | |||
| 0.021 | 0.008 | 0.021 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.011 CID_123074 | ||
| 0.053 | 0.04 | 0.053 | Carbonic anhydrase I inhibitor | |||
| 0.023 | 0.01 | 0.023 | Factor XIII inhibitor | |||
| 0.03 | 0.017 | 0.03 | Thrombin receptor antagonist | |||
| 0.035 | 0.022 | 0.035 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.029 | 0.017 | 0.029 | Lysine carboxypeptidase inhibitor | 0.025 0.02 CID_123074 | ||
| 0.183 | 0.171 | 0.197 | Thyroid hormone beta antagonist | 0.179 0.174 CID_439929 0.186 0.167 CID_9543118 0.197 0.157 CID_123074 | CID_123074 | |
| 0.026 | 0.014 | 0.026 | Prostaglandin EP2 agonist | |||
| 0.029 | 0.017 | 0.029 | HCV NS5A inhibitor | |||
| 0.017 | 0.005 | 0.017 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.057 | 0.045 | 0.057 | Collagenase 3 inhibitor | |||
| 0.033 | 0.021 | 0.048 | Estrogen-related receptor beta antagonist | 0.046 0.007 CID_439929 0.046 0.007 CID_9543118 0.048 0.006 CID_123074 | CID_123074 | |
| 0.043 | 0.032 | 0.65 | Dopamine D2 agonist | 0.65 0.003 CID_439929 0.408 0.004 CID_9543118 0.342 0.004 CID_123074 | CID_439929 | |
| 0.023 | 0.012 | 0.023 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.053 | 0.041 | 0.053 | Carbonic anhydrase II inhibitor | |||
| 0.036 | 0.025 | 0.036 | Inosine monophosphate dehydrogenase inhibitor | 0.035 0.026 CID_123074 | ||
| 0.024 | 0.013 | 0.024 | Kainate receptor 1 antagonist | |||
| 0.089 | 0.078 | 0.089 | Insulin receptor antagonist | |||
| 0.022 | 0.011 | 0.022 | Toll-Like receptor 8 agonist | |||
| 0.029 | 0.019 | 0.029 | CDK4/cyclin D3 inhibitor | |||
| 0.02 | 0.009 | 0.02 | CXC chemokine 5 receptor antagonist | |||
| 0.03 | 0.02 | 0.03 | AMPA 3 receptor antagonist | |||
| 0.055 | 0.045 | 0.055 | Cathepsin L inhibitor | |||
| 0.048 | 0.038 | 0.048 | Dopamine D4 agonist | |||
| 0.016 | 0.006 | 0.016 | Carbonic anhydrase XI inhibitor | |||
| 0.055 | 0.045 | 0.055 | Protein kinase C iota inhibitor | 0.052 0.049 CID_439929 | ||
| 0.067 | 0.058 | 0.067 | MAP kinase 14 inhibitor | |||
| 0.053 | 0.044 | 0.053 | MAP kinase kinase 9 inhibitor | |||
| 0.012 | 0.003 | 0.012 | DNA topoisomerase III inhibitor | 0.009 0.004 CID_123074 | ||
| 0.039 | 0.03 | 0.039 | DNA-dependent protein kinase inhibitor | |||
| 0.152 | 0.143 | 0.687 | Free radical scavenger | 0.687 0.005 CID_439929 0.661 0.006 CID_9543118 0.553 0.012 CID_123074 | CID_439929 | |
| 0.019 | 0.011 | 0.023 | Estrogen-related receptor gamma agonist | 0.023 0.007 CID_439929 0.023 0.007 CID_9543118 0.022 0.007 CID_123074 | CID_9543118 | |
| 0.073 | 0.065 | 0.073 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.044 | 0.035 | 0.044 | Carbonic anhydrase VII inhibitor | 0.043 0.036 CID_439929 0.043 0.036 CID_9543118 0.041 0.039 CID_123074 | ||
| 0.043 | 0.035 | 0.043 | Phosphorylase inhibitor | |||
| 0.033 | 0.025 | 0.033 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.032 | 0.024 | 0.032 | Growth hormone releasing factor agonist | |||
| 0.015 | 0.006 | 0.015 | Cyclin D2 inhibitor | |||
| 0.018 | 0.009 | 0.018 | Nicotinic alpha4 receptor agonist | |||
| 0.091 | 0.083 | 0.091 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.014 | 0.006 | 0.015 | Glutamate (mGluR6) agonist | 0.013 0.008 CID_439929 0.013 0.008 CID_9543118 0.015 0.006 CID_123074 | CID_123074 | |
| 0.014 | 0.006 | 0.014 | Melatonin 2 antagonist | |||
| 0.043 | 0.035 | 0.043 | Dipeptidyl peptidase IV inhibitor | |||
| 0.017 | 0.009 | 0.017 | Purinergic P2Y1 agonist | 0.016 0.01 CID_123074 | ||
| 0.028 | 0.02 | 0.028 | Cyclin E2 inhibitor | |||
| 0.015 | 0.008 | 0.015 | Melatonin receptor 1A antagonist | |||
| 0.056 | 0.049 | 0.062 | Dopamine D3 antagonist | 0.062 0.043 CID_439929 0.056 0.049 CID_9543118 0.057 0.048 CID_123074 | CID_439929 | |
| 0.019 | 0.012 | 0.019 | Apolipoprotein B-100 inhibitor | |||
| 0.044 | 0.037 | 0.044 | Glycine transporter inhibitor | |||
| 0.086 | 0.079 | 0.086 | MAP kinase 8 inhibitor | |||
| 0.057 | 0.05 | 0.099 | Bcl-xL inhibitor | 0.074 0.016 CID_439929 0.099 0.006 CID_9543118 0.078 0.013 CID_123074 | CID_9543118 | |
| 0.032 | 0.025 | 0.032 | Calcitonin receptor agonist | |||
| 0.024 | 0.017 | 0.024 | NMDA receptor glycine site antagonist | |||
| 0.032 | 0.025 | 0.032 | ATR kinase inhibitor | |||
| 0.021 | 0.015 | 0.021 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.012 | 0.005 | 0.012 | Angiotensin AT2 receptor agonist | |||
| 0.009 | 0.003 | 0.009 | CC chemokine 6 receptor agonist | |||
| 0.017 | 0.01 | 0.017 | CDK2/cyclin A3 inhibitor | |||
| 0.013 | 0.007 | 0.013 | Egl nine homolog 3 inhibitor | 0.012 0.008 CID_123074 | ||
| 0.079 | 0.073 | 0.079 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.023 | 0.017 | 0.023 | Dopamine autoreceptor agonist | |||
| 0.106 | 0.1 | 0.106 | Tyrosine-protein kinase receptor antagonist | |||
| 0.017 | 0.011 | 0.017 | G-protein-coupled receptor 120 agonist | |||
| 0.053 | 0.047 | 0.053 | Kallikrein 1 inhibitor | |||
| 0.031 | 0.025 | 0.036 | Melatonin 2 agonist | 0.036 0.019 CID_9543118 | CID_9543118 | |
| 0.029 | 0.024 | 0.032 | Prostaglandin agonist | 0.028 0.026 CID_9543118 0.032 0.02 CID_123074 | CID_123074 | |
| 0.021 | 0.015 | 0.021 | Geranylgeranyltransferase I inhibitor | |||
| 0.018 | 0.012 | 0.018 | Progesterone agonist | |||
| 0.05 | 0.045 | 0.05 | Pim-2 kinase inhibitor | |||
| 0.029 | 0.024 | 0.029 | Dipeptidyl peptidase I inhibitor | |||
| 0.065 | 0.06 | 0.065 | Epoxide hydrolase inhibitor | |||
| 0.055 | 0.05 | 0.055 | Acetylcholine M2 receptor antagonist | |||
| 0.065 | 0.06 | 0.065 | MAP kinase 11 inhibitor | |||
| 0.017 | 0.012 | 0.018 | Ileal bile acid transport inhibitor | 0.018 0.011 CID_439929 0.017 0.012 CID_123074 | CID_439929 | |
| 0.021 | 0.017 | 0.021 | Alpha 1a adrenoreceptor agonist | |||
| 0.025 | 0.021 | 0.034 | CXC chemokine 2 receptor antagonist | 0.034 0.01 CID_123074 | CID_123074 | |
| 0.052 | 0.048 | 0.058 | Dopamine D4 antagonist | 0.058 0.043 CID_439929 | CID_439929 | |
| 0.008 | 0.004 | 0.008 | Integrin alpha5beta6 antagonist | |||
| 0.034 | 0.03 | 0.034 | Melanocortin 1 antagonist | |||
| 0.015 | 0.011 | 0.015 | CXC chemokine 4 receptor agonist | |||
| 0.051 | 0.048 | 0.052 | Adenosine A1 receptor antagonist | 0.052 0.047 CID_123074 | CID_123074 | |
| 0.026 | 0.023 | 0.026 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.13 | 0.127 | 0.244 | Amyloid beta precursor protein antagonist | 0.188 0.065 CID_439929 0.244 0.035 CID_9543118 0.226 0.043 CID_123074 | CID_9543118 | |
| 0.016 | 0.014 | 0.016 | CC chemokine 9 receptor antagonist | |||
| 0.035 | 0.032 | 0.035 | Cathepsin L1 inhibitor | |||
| 0.044 | 0.041 | 0.05 | Thromboxane A2 antagonist | 0.05 0.036 CID_123074 | CID_123074 | |
| 0.047 | 0.045 | 0.052 | Thromboxane antagonist | 0.052 0.039 CID_123074 | CID_123074 | |
| 0.031 | 0.029 | 0.031 | RNA-directed RNA polymerase inhibitor | 0.031 0.03 CID_123074 | ||
| 0.036 | 0.034 | 0.036 | Toll-Like receptor 2 agonist | |||
| 0.082 | 0.08 | 0.082 | Butyrylcholinesterase inhibitor | |||
| 0.083 | 0.081 | 0.083 | ABCA1 expression enhancer | |||
| 0.018 | 0.017 | 0.018 | Caspase 8 inhibitor | 0.018 0.017 CID_123074 | ||
| 0.01 | 0.008 | 0.01 | Purinergic P2Y2 agonist | |||
| 0.017 | 0.016 | 0.017 | 5-Alpha-reductase 2 inhibitor | |||
| 0.033 | 0.032 | 0.033 | Factor XIIIa inhibitor | |||
| 0.102 | 0.101 | 0.168 | Acetylcholinesterase inhibitor | 0.118 0.08 CID_439929 0.168 0.045 CID_9543118 0.156 0.052 CID_123074 | CID_9543118 | |
| 0.025 | 0.024 | 0.025 | Melatonin antagonist | |||
| 0.043 | 0.042 | 0.043 | Metalloproteinase-3 inhibitor | |||
| 0.01 | 0.009 | 0.01 | Thromboxane agonist | |||
| 0.016 | 0.016 | 0.018 | Retinoic acid receptor antagonist | 0.018 0.014 CID_123074 | CID_123074 | |
| 0.018 | 0.018 | 0.023 | Retinoic acid alpha receptor antagonist | 0.02 0.014 CID_9543118 0.023 0.011 CID_123074 | CID_123074 | |
| 0.023 | 0.024 | 0.033 | Thyroid hormone agonist | 0.026 0.017 CID_439929 0.033 0.01 CID_9543118 0.032 0.01 CID_123074 | CID_9543118 | |
| 0.02 | 0.02 | 0.022 | Prostaglandin E2 agonist | 0.022 0.017 CID_123074 | CID_123074 | |
| 0.012 | 0.014 | 0.015 | Egl nine homolog 1 inhibitor | 0.015 0.01 CID_123074 | CID_123074 | |
| 0.042 | 0.045 | 0.048 | Beta adrenoreceptor agonist | 0.047 0.025 CID_439929 0.048 0.023 CID_9543118 0.046 0.029 CID_123074 | CID_9543118 | |
| 0.079 | 0.082 | 0.091 | Breast cancer-resistant protein inhibitor | 0.091 0.064 CID_9543118 | CID_9543118 | |
| 0.046 | 0.049 | 0.098 | Glucose-6-phosphate translocase inhibitor | 0.098 0.006 CID_439929 0.081 0.011 CID_9543118 0.068 0.017 CID_123074 | CID_439929 | |
| 0.155 | 0.16 | 0.678 | Antioxidant | 0.678 0.007 CID_439929 0.645 0.008 CID_9543118 0.56 0.014 CID_123074 | CID_439929 | |
| 0.045 | 0.053 | 0.089 | Plasminogen activator inhibitor | 0.056 0.043 CID_439929 0.077 0.028 CID_9543118 0.089 0.021 CID_123074 | CID_123074 | |
| 0.133 | 0.142 | 0.427 | Antimitotic | 0.427 0.019 CID_439929 0.305 0.042 CID_9543118 0.233 0.067 CID_123074 | CID_439929 | |
| 0.055 | 0.068 | 0.09 | Dopamine antagonist | 0.09 0.043 CID_439929 0.072 0.052 CID_9543118 0.064 0.059 CID_123074 | CID_439929 | |
| 0.048 | 0.062 | 0.076 | Purinergic P2X2 antagonist | 0.076 0.042 CID_123074 | CID_123074 | |
| 0.017 | 0.031 | 0.022 | Beta 1 adrenoreceptor agonist | 0.022 0.018 CID_9543118 | CID_9543118 | |
| 0.032 | 0.046 | 0.039 | Retinoic acid alpha receptor agonist | 0.039 0.028 CID_123074 | CID_123074 | |
| 0.031 | 0.048 | 0.056 | Urokinase inhibitor | 0.042 0.038 CID_9543118 0.056 0.03 CID_123074 | CID_123074 | |
| 0.003 | 0.02 | 0.009 | Insulin like growth factor 3 antagonist | 0.009 0.003 CID_439929 0.009 0.003 CID_9543118 | CID_9543118 | |
| 0.128 | 0.145 | 0.157 | Lipocortins synthesis antagonist | 0.157 0.095 CID_123074 | CID_123074 | |
| 0.204 | 0.222 | 0.269 | DNA polymerase beta inhibitor | 0.254 0.19 CID_439929 0.269 0.182 CID_9543118 0.247 0.194 CID_123074 | CID_9543118 | |
| 0.016 | 0.036 | 0.296 | Dopamine D1 agonist | 0.296 0.002 CID_439929 0.172 0.003 CID_9543118 0.12 0.003 CID_123074 | CID_439929 | |
| 0.016 | 0.037 | 0.029 | Leukotriene B4 receptor 1 antagonist | 0.029 0.018 CID_9543118 0.025 0.022 CID_123074 | CID_9543118 | |
| 0.024 | 0.045 | 0.17 | Catechol O-methyltransferase inhibitor | 0.166 0.004 CID_439929 0.17 0.003 CID_9543118 0.095 0.005 CID_123074 | CID_9543118 | |
| 0.036 | 0.058 | 0.218 | Aldose reductase inhibitor | 0.218 0.006 CID_439929 0.177 0.008 CID_9543118 0.166 0.009 CID_123074 | CID_439929 | |
| 0.043 | 0.066 | 0.077 | Dopamine D2 antagonist | 0.077 0.041 CID_439929 0.059 0.05 CID_9543118 | CID_439929 | |
| 0.014 | 0.038 | 0.026 | Leukotriene B4 receptor 2 antagonist | 0.026 0.011 CID_9543118 0.025 0.012 CID_123074 | CID_9543118 | |
| 0.026 | 0.05 | 0.037 | Protein kinase C beta II inhibitor | 0.037 0.015 CID_439929 0.032 0.024 CID_9543118 0.036 0.016 CID_123074 | CID_439929 | |
| 0.185 | 0.209 | 0.376 | Sodium/bile acid cotransporter inhibitor | 0.376 0.026 CID_439929 0.345 0.043 CID_9543118 0.36 0.034 CID_123074 | CID_439929 | |
| 0.024 | 0.051 | 0.045 | Dopamine D3 agonist | 0.045 0.023 CID_439929 0.043 0.024 CID_9543118 0.036 0.032 CID_123074 | CID_439929 | |
| 0.05 | 0.078 | 0.08 | Bcl2 antagonist | 0.08 0.032 CID_9543118 | CID_9543118 | |
| 0.081 | 0.111 | 0.196 | DNA polymerase I inhibitor | 0.174 0.037 CID_439929 0.196 0.029 CID_9543118 0.154 0.047 CID_123074 | CID_9543118 | |
| 0.107 | 0.137 | 0.147 | Farnesoid X receptor antagonist | 0.137 0.07 CID_439929 0.147 0.055 CID_9543118 0.139 0.067 CID_123074 | CID_9543118 | |
| 0.196 | 0.231 | 0.269 | DNA directed DNA polymerase inhibitor | 0.253 0.19 CID_439929 0.269 0.18 CID_9543118 0.253 0.19 CID_123074 | CID_9543118 | |
| 0.137 | 0.176 | 0.334 | Tumour necrosis factor alpha release inhibitor | 0.333 0.043 CID_439929 0.334 0.042 CID_9543118 0.246 0.077 CID_123074 | CID_9543118 | |
| 0.044 | 0.083 | 0.097 | Lipase inhibitor | 0.097 0.029 CID_439929 0.082 0.041 CID_9543118 | CID_439929 | |
| 0.011 | 0.052 | 0.017 | Antibiotic Tetracycline-like | 0.015 0.012 CID_9543118 0.017 0.007 CID_123074 | CID_123074 | |
| 0.108 | 0.159 | 0.381 | Nitric oxide antagonist | 0.381 0.028 CID_439929 0.343 0.033 CID_9543118 0.306 0.039 CID_123074 | CID_439929 | |
| 0.04 | 0.092 | 0.494 | HIV-1 integrase (3'-Processing) inhibitor | 0.494 0.004 CID_439929 0.467 0.004 CID_9543118 0.365 0.004 CID_123074 | CID_439929 | |
| 0.008 | 0.061 | 0.017 | Thyroid hormone alpha antagonist | 0.014 0.012 CID_439929 0.017 0.01 CID_9543118 0.016 0.01 CID_123074 | CID_9543118 | |
| 0.061 | 0.115 | 0.098 | Bronchodilator | 0.098 0.066 CID_9543118 0.085 0.08 CID_123074 | CID_9543118 | |
| 0.029 | 0.094 | 0.084 | Maillard reaction inhibitor | 0.066 0.031 CID_439929 0.084 0.023 CID_9543118 0.079 0.025 CID_123074 | CID_9543118 | |
| 0.037 | 0.103 | 0.061 | Factor III inhibitor | 0.061 0.017 CID_439929 0.061 0.017 CID_9543118 0.059 0.019 CID_123074 | CID_9543118 | |
| 0.027 | 0.094 | 0.064 | Plasminogen activator inhibitor antagonist | 0.045 0.04 CID_439929 0.064 0.021 CID_9543118 | CID_9543118 | |
| 0.03 | 0.098 | 0.425 | HIV-1 integrase (Strand Transfer) inhibitor | 0.425 0.004 CID_439929 0.399 0.004 CID_9543118 0.355 0.004 CID_123074 | CID_439929 | |
| 0.163 | 0.244 | 0.324 | Apoptosis antagonist | 0.317 0.074 CID_439929 0.324 0.07 CID_9543118 0.259 0.119 CID_123074 | CID_9543118 | |
| 0.065 | 0.149 | 0.185 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.16 0.056 CID_439929 0.185 0.046 CID_9543118 0.117 0.085 CID_123074 | CID_9543118 | |
| 0.093 | 0.179 | 0.144 | Insulin secretagoues | 0.142 0.083 CID_439929 0.144 0.081 CID_9543118 | CID_9543118 | |
| 0.105 | 0.193 | 0.214 | P-glycoprotein inhibitor | 0.214 0.056 CID_439929 0.192 0.069 CID_9543118 0.19 0.071 CID_123074 | CID_439929 | |
| 0.1 | 0.189 | 0.224 | Interleukin antagonist | 0.196 0.086 CID_439929 0.224 0.072 CID_9543118 0.187 0.092 CID_123074 | CID_9543118 | |
| 0.04 | 0.129 | 0.069 | Adenine nucleotide translocase inhibitor | 0.069 0.017 CID_439929 0.069 0.017 CID_9543118 0.065 0.02 CID_123074 | CID_9543118 | |
| 0.042 | 0.133 | 0.104 | Potassium channel large-conductance Ca-activated activator | 0.079 0.036 CID_9543118 0.104 0.022 CID_123074 | CID_123074 | |
| 0.068 | 0.159 | 0.194 | Bone formation stimulant | 0.179 0.042 CID_439929 0.181 0.041 CID_9543118 0.194 0.037 CID_123074 | CID_123074 | |
| 0.096 | 0.209 | 0.254 | Interleukin 6 antagonist | 0.202 0.039 CID_439929 0.254 0.022 CID_9543118 0.239 0.025 CID_123074 | CID_9543118 | |
| 0.111 | 0.227 | 0.404 | Vasodilator | 0.404 0.022 CID_439929 0.309 0.045 CID_9543118 0.282 0.055 CID_123074 | CID_439929 | |
| 0.115 | 0.248 | 0.292 | Hypoglycemic | 0.282 0.06 CID_439929 0.292 0.055 CID_9543118 0.25 0.077 CID_123074 | CID_9543118 | |
| 0.038 | 0.176 | 0.289 | HIV-1 integrase inhibitor | 0.289 0.004 CID_439929 0.261 0.004 CID_9543118 0.239 0.004 CID_123074 | CID_439929 | |
| 0.006 | 0.145 | 0.016 | Thyroid hormone alpha agonist | 0.016 0.013 CID_9543118 0.016 0.013 CID_123074 | CID_123074 | |
| 0.035 | 0.188 | 0.08 | Antiadrenergic | 0.077 0.074 CID_439929 0.08 0.071 CID_9543118 | CID_9543118 | |
| 0.033 | 0.191 | 0.076 | Adrenaline antagonist | 0.076 0.072 CID_9543118 | CID_9543118 | |
| 0.046 | 0.206 | 0.382 | Chelator | 0.335 0.009 CID_439929 0.382 0.006 CID_9543118 0.34 0.008 CID_123074 | CID_9543118 | |
| 0.055 | 0.221 | 0.157 | Thrombolytic | 0.157 0.076 CID_439929 0.137 0.092 CID_9543118 | CID_439929 | |
| 0.022 | 0.19 | 0.069 | HIV-1 reverse transcriptase inhibitor | 0.069 0.05 CID_439929 0.066 0.053 CID_9543118 | CID_439929 | |
| 0.182 | 0.36 | 0.564 | Antiinflammatory | 0.564 0.064 CID_439929 0.546 0.07 CID_9543118 0.489 0.092 CID_123074 | CID_439929 | |
| 0.015 | 0.197 | 0.075 | Opioid delta receptor antagonist | 0.056 0.049 CID_9543118 0.075 0.038 CID_123074 | CID_123074 | |
| 0.027 | 0.224 | 0.068 | Vanilloid 2 antagonist | 0.068 0.015 CID_439929 0.068 0.015 CID_9543118 0.048 0.047 CID_123074 | CID_9543118 | |
| 0.038 | 0.237 | 0.093 | Opioid kappa receptor antagonist | 0.078 0.061 CID_9543118 0.093 0.042 CID_123074 | CID_123074 | |
| 0.059 | 0.265 | 0.372 | Dual specificity phosphatase 3 inhibitor | 0.372 0.017 CID_439929 0.36 0.019 CID_9543118 0.361 0.019 CID_123074 | CID_439929 | |
| 0.065 | 0.273 | 0.414 | Dual specificity phosphatase inhibitor | 0.361 0.019 CID_439929 0.398 0.014 CID_9543118 0.414 0.013 CID_123074 | CID_123074 | |
| 0.016 | 0.233 | 0.104 | Selectin antagonist | 0.074 0.04 CID_439929 0.104 0.026 CID_9543118 0.089 0.032 CID_123074 | CID_9543118 | |
| 0.069 | 0.292 | 0.347 | Hepatoprotectant | 0.347 0.019 CID_439929 0.284 0.034 CID_9543118 0.263 0.04 CID_123074 | CID_439929 | |
| 0.087 | 0.318 | 0.227 | Thioredoxin glutathione reductase inhibitor | 0.192 0.179 CID_439929 0.218 0.157 CID_9543118 0.227 0.15 CID_123074 | CID_123074 | |
| 0.046 | 0.29 | 0.117 | Toll-Like receptor 4 antagonist | 0.117 0.047 CID_439929 0.117 0.047 CID_9543118 0.117 0.047 CID_123074 | CID_123074 | |
| 0.013 | 0.259 | 0.064 | Opioid mu receptor antagonist | 0.064 0.051 CID_123074 | CID_123074 | |
| 0.011 | 0.258 | 0.157 | Antineoplastic antibiotic | 0.143 0.032 CID_439929 0.127 0.036 CID_9543118 0.157 0.029 CID_123074 | CID_123074 | |
| 0.03 | 0.279 | 0.086 | Opioid antagonist | 0.086 0.062 CID_123074 | CID_123074 | |
| 0.021 | 0.274 | 0.062 | CDK1/cyclin B1 inhibitor | 0.062 0.058 CID_439929 | CID_439929 | |
| 0.02 | 0.312 | 0.063 | CXC chemokine 1 receptor antagonist | 0.051 0.035 CID_9543118 0.063 0.019 CID_123074 | CID_123074 | |
| 0.012 | 0.318 | 0.064 | Neuraminidase (Influenza A) inhibitor | 0.06 0.012 CID_439929 0.056 0.017 CID_9543118 0.064 0.01 CID_123074 | CID_123074 | |
| 0.033 | 0.352 | 0.342 | Lipid peroxidase inhibitor | 0.339 0.014 CID_439929 0.342 0.014 CID_9543118 0.288 0.02 CID_123074 | CID_9543118 | |
| 0.109 | 0.435 | 0.236 | Interleukin 2 agonist | 0.236 0.135 CID_123074 | CID_123074 | |
| 0.105 | 0.463 | 0.32 | Cyclophilin D inhibitor | 0.305 0.158 CID_439929 0.32 0.145 CID_9543118 0.251 0.212 CID_123074 | CID_9543118 | |
| 0.036 | 0.394 | 0.097 | Vanilloid agonist | 0.093 0.042 CID_439929 0.097 0.036 CID_9543118 | CID_9543118 | |
| 0.041 | 0.439 | 0.178 | Platelet adhesion inhibitor | 0.178 0.083 CID_439929 0.164 0.092 CID_9543118 0.139 0.119 CID_123074 | CID_439929 | |
| 0.025 | 0.497 | 0.267 | Angiogenesis stimulant | 0.267 0.062 CID_439929 0.248 0.071 CID_9543118 0.237 0.076 CID_123074 | CID_439929 | |
| 0.009 | 0.49 | 0.091 | Neuraminidase (influenza) inhibitor | 0.089 0.02 CID_439929 0.091 0.019 CID_9543118 0.089 0.02 CID_123074 | CID_9543118 | |
| 0.082 | 0.587 | 0.182 | Peptidyltransferase inhibitor | 0.182 0.124 CID_439929 0.182 0.124 CID_9543118 0.177 0.133 CID_123074 | CID_9543118 | |
| 0.006 | 0.528 | 0.084 | Neuraminidase inhibitor | 0.081 0.025 CID_439929 0.084 0.023 CID_9543118 0.083 0.023 CID_123074 | CID_9543118 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |